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Abstract 
The tissue-specific transcription factors, HNF1α and HNF1β, are two closely related 
homeodomain proteins that are conserved throughout vertebrate evolution. Heterozygous 
mutations in the human HNF1β and HNF1α genes are linked to maturity onset diabetes of 
the young (MODY), but mutated HNF1β is also associated with kidney malformations. 
Consistent with this, it has been demonstrated that overexpression of HNF1β in Xenopus 
embryos leads to defective pronephric development and agenesis of the pronephros, while 
HNF1α has no effect on kidney development. The regions in the HNF1β protein 
responsible for this functional difference were defined in transfected HeLa cells as well as 
in injected Xenopus embryos. Using domain swapping experiments a nuclear localization 
signal was localized in the POUH domain of HNF1β. The POUS and POUH domains of 
HNF1β also were responsible for the most of the transactivation activity in transfected 
cells. In injected Xenopus embryos, three HNF1β domains are involved in nephrogenesis. 
These include the dimerization domain, the 26 aa segment specific for splice variant A as 
well as the POUH domain. HNF1β together with Pax8 and lim1 constitute the earliest 
regulators in the pronephric anlage. Overexpression of lim1 together with Pax8 in Xenopus 
embryos led to an enlarged pronephros with ectopic pronephric structures. In an effort to 
evaluate whether HNFβ antagonizes the nephrogenic effect of lim1 and Pax8, all three 
transcription factors were coinjected into Xenopus embryos. The data shown here that 
HNF1β can overcome the enlargement and the induction of an ectopic pronephros mediated 
by overexpression of Pax8 and lim1. But the phenotype induced by Pax8 and lim1 
overexpression and characterized by cyst-like structures and thickening of the pronephric 
tubules was not altered by HNF1β overexpression. Taken together, HNF1β acts 
antagonistically to Pax8 and lim1 in only some processes during nephrogenesis, and a 
simple antagonistic relationship does not completely describe the functions of these genes. I 
conclude that HNF1β has some distinct morphogenetic properties during nephrogenesis.  
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I. Introduction 
1. Transcription factors 
Eukaryotes employ diverse mechanisms to regulate gene expression, including chromatin 
condensation, DNA methylation, transcriptional initiation, alternative splicing of RNA, 
mRNA stability, translational controls, several forms of post-translational modification, 
intracellular trafficking, and protein degradation. The rate of transcriptional initiation (when 
and how often a given gene is transcribed) is the most important point of control. The 
transcription of each gene is controlled by gene regulatory proteins known as transcription 
factors. Eukaryotic genes that encode proteins are transcribed by the RNA polymerase II 
with the help of general transcription factors to position the RNA polymerase correctly at 
the basal promoter and pull apart the two strands of DNA to allow transcription to begin. 
The basal promoter is a 100-bp region whose function is to provide a docking site for the 
transcription complex and position the start of transcription relative to coding sequences 
(Reinberg et al., 1998; Lee and Young, 2000). General transcription factors are termed 
general because they assemble on all promoters used by polymerase II. This group includes 
10 to 12 proteins, most of them being ubiquitously expressed, and therefore, providing little 
regulatory specificity (Orphanides et al., 1996; Lee and Young, 2000). 
Only some of the genes in an eukaryotic cell are expressed at any given moment. The 
proportion and composition of transcribed genes change considerably during the life cycle, 
among cell types, and in response to fluctuating physiological and environmental conditions 
(White et al., 1999; Iyer et al., 2001; Kayo et al., 2001; Mody et al., 2001; Arbeitman et al., 
2002). Producing functionally significant levels of mRNA requires the sequence-specific 
association of transcription factors with DNA sequences outside the basal promoter (Lemon 
and Tjian, 2000). These specific transcription factors bind their specific DNA sequences 
and recruit cofactors to attract, position and modify the general transcription factors and 
RNA polymerase II at the promoter so that transcription can begin (Roeder, 1998; Lee and 
Young, 2000; Orphanides and Reinberg, 2002).  
 
Introduction   3
Most transcription factors that activate gene transcription have a modular design consisting 
of at least two distinct domains. The DNA binding domain usually contains one of the 
structural motifs that recognizes a specific regulatory DNA sequence. A second domain, 
sometimes called an activation domain, accelerates the rate of transcription initiation. 
Some of the known DNA binding proteins are restricted to a cell lineage. They interact with 
DNA sequences necessary for tissue-specific activation or repression of genes, and cause 
the correct spatial and temporal pattern of gene expression. For example, the sequence 
encoding the muscle determination factor (MyoD) belongs to a superfamily of basic helix-
loop-helix (bHLH) transcription factors (Rudnicki and Jaenisch, 1995). It plays a dominant 
role in myogenesis, and has the ability to convert fibroblasts into myogenic cells. However, 
only few of the tissue-specific transcription factors are sufficient to confer phenotype to a 
cell. Most of the transcription factors cannot be considered as a ‘master gene’ for the 
phenotype. For example, the hepatocyte nuclear factor 1 family (HNF1), containing HNF1α 
(HNF1α, also named HNF1 or TCF1) and HNF1β ( also named vHNF1 or TCF2), were 
initially identified as transcription factors enriched in the liver (Bach et al., 1991). In 
addition to the liver, HNF1 is also expressed in the kidney, pancreas and intestine, whereas,  
HNF1β in addition is expressed in the lung and testis. HNF1α regulates numerous liver 
specific genes, and its expression appears linked to the hepatic phenotype. In addition to the 
HNF1 family, four other families of transcription factors have been isolated that are 
involved in the liver-specific regulation of different genes: C/EBP, HNF3, DBP and HNF4. 
None of these factors can singly account for the determination of the liver differentiation 
program. It is most likely that they participate a network of regulators in hepatocytes to 
define the hepatic phenotype. 
2. The tissue-specific transcription factors, HNF1α and HNF1β 
Duplication of developmental control genes is thought to be an evolutionary mechanism for 
the generation of novel functions allowing for increased diversity in complex organisms. It 
provides an organism with a cornucopia of spare gene copies, which are free to mutate to 
serve divergent purposes. The related duplicated genes often remain functional while 
changes in their sequence and expression pattern occur and they take on different functional 
 
Introduction   4
roles. In many cases, the most obvious functional differences between the duplicated genes 
is that they are expressed in different tissues or at different stages of development (Amores 
et al., 1998; Kawazoe et al., 2002). The genes encoding the tissue-specific transcription 
factors, HNF1α and HNF1β, have arisen from an ancestral gene at the onset of vertebrate 
evolution (Deryckere et al., 1995). They are highly conserved in vertebrates with homologs 
in fish (Deryckere et al., 1995; Sun and Hopkins, 2001), frog (Bartkowski et al., 1993; 
Demartis et al., 1994) and mammals (Frain et al., 1989). They are encoded as distinct genes 
on separate chromosomes. In humans, HNF1α and HNF1β are located on chromosomes 12 
and 17, respectively. The exon-intron pattern in genome encoding for HNF1α and HNF1β 
is conserved in vertebrate species, and is essentially the same between Xenopus and 
mammals (Zapp et al., 1993).  
2.1 Functional regions of the HNF1 proteins 
The transcription factors, HNF1α and HNF1β, are two related tissue-specific transcription 
factors of the homeodomain family (Gehring et al., 1994). They are two unique members of 
this gene family as they contain an extra 21 amino acid loop between helices 2 and 3 
(Cereghini, 1996). Both HNF1 proteins contain a highly conserved N-terminal dimerization 
domain, a bipartite DNA binding region and a more divergent C-terminal transactivation 
domain (Figure 1). Based on the crystal structure, the dimerization domain in the dimer has 
been identified as an intertwined four-helix bundle that allows the formation of homo- or 
heterodimers of the HNF1 proteins (Rose et al., 2000; Narayana et al., 2001). A 
dimerization cofactor termed DCoH binds to the dimerization domain of HNF1 factors, and 
stabilizes the active dimeric form. (Rose et al., 2000).  
The DNA binding domain is composed of a POU-A related domain (POUS) and the 
divergent homeodomain, POUH. The POUS domain is strictly conserved between the α and 
β proteins (98% identity of the amino acid sequence), indicating that it is crucial for the 
overall DNA binding activity of HNF1. Only nine out of 90 residues within POUH differ 
between HNF1α and HNF1β, six of which are conservative changes. Together POUS and 
POUH bind to the palindromic 13 bp consensus sequence, GTTAATNATTANC (Courtois 
et al., 1988). Recent three-dimensional structural analysis of the HNF1α protein indicates 
that the POUS domain interacts with the 21 aa loop of the POUH domain to create a stable 
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interface between the two DNA binding domains, and that this rigidity is necessary for 
normal function. This feature distinguishes HNF1α from other more flexible POU-
homeodomain factors including Pit1 and Oct1, where flexibility is critical for their DNA 
binding (Chi et al., 2002). Since the primary structures of HNF1α and HNF1β within the 
dimerization as well as the DNA binding regions are very similar, it is not surprising that 
HNF1α and HNF1β bind DNA as homo- or heterodimers and display indistinguishable 
DNA binding sequence specificity (De Simone et al., 1991; Rey-Campos et al., 1991; Bach 
et al., 1991; Cereghini, 1996).  
The transactivation domains of the HNF1α and HNF1β proteins are the most divergent 
regions of the primary structure. The glycine/proline-rich stretch downstream to the 
homeodomain in HNF1α (288-308 aa in HNF1α) is absent in HNF1β. This region has been 
proposed to function as a potential hinge structure in the HNF1α protein (Chouard et al., 
1990), and to be essential for transcriptional activation by HNF1α (Nicosia et al., 1990). 
This may also explain why HNF1α is a more powerful activator than HNF1β (Rey-Campos 
et al., 1991).  
The N-terminal region of HNF1β differs from that of HNF1α, in that it contains a 26 aa 
insertion between the POUS and POUH domains (Figure 1). Two isoforms of HNF1β 
designated HNF1β-A and -B, resulting from alternative exon 2 usage, are always present, 
albeit at different levels, in all tissues where HNF1β is expressed (Ringeisen et al., 1993; 
Cereghini et al., 1992; Bach and Yaniv, 1993). This 26 aa segment is only present in 
isoform HNF1β-A, and absent in splice variant HNF1β-B. Moreover, this segment is found 
in the mammalian as well as in Xenopus HNF1β proteins, and the sequence is highly 
conserved from Xenopus to humans (Figure 1). Taken together, these findings indicate that 
this 26 aa segment plays a specific role for HNF1β function. 
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ure 1: The related human transcription factors, HNF1α and HNF1β. Above, HNF1β and HNF1α are 
resented schematically. The domains are indicated and numbers refer to the amino acid positions. Amino 
d identity of the domains between HNF1α and HNF1β is shown in bold face. Below, the 26 aa segment 
tween the POUS and POUH domains of the human HNF1α and HNF1β proteins as well as of the human 
d Xenopus HNF1β protein are aligned. The 26 aa segment deleted in the B splice variant of the HNF1β is 
icated. Identical amino acids between β and α or human β and Xenopus β sequences are shown and 
nserved amino acid changes are indicated by +.  
2 HNF1 expression during development 
 murine embryogenesis, HNF1α and HNF1β are coexpressed in the yolk sac endoderm as 
ll as in developing liver, kidney, and pancreas, although with different spatio-temporal 
tterns (Lazzaro et al., 1992; Ott et al., 1991; Cereghini et al., 1992; Barbacci et al., 1999; 
ffinier et al., 1999a). Transcription of HNF1β precedes that of HNF1α, and starts during 
e earliest stages of organogenesis. HNF1α appears in the visceral endoderm of the yolk 
c at approximately 8.5 d. p.c., and in the liver and pancreatic buds at 10.5 d. p.c. 
ereghini et al., 1992; Nammo et al., 2002). In contrast, HNF1β is uniquely expressed in 
e primitive and visceral endoderm from 4.5 to 7.5 d. p.c. and in the liver, pancreatic, and 
eteric buds at 9.5-11 d. p.c.. (Barbacci et al., 1999). In addition, HNF1β is expressed in 
e forming neural tube, lungs, and genital tract, where HNF1α is absent (Barbacci et al., 
99; Coffinier et al., 1999b; Reber and Cereghini, 2001).  
Introduction   7
The embryonic expression pattern of the HNF1 proteins is evolutionarily conserved in the 
vertebrates. The expression of HNF1β occurs prior to HNF1α in Xenopus embryo (Weber 
et al., 1996; Pogge v.Strandmann et al., 1997), and only HNF1β is expressed in the 
developing brain in Xenopus as well as in Zebrafish (Demartis et al., 1994; Sun and 
Hopkins, 2001). In Xenopus, HNF1β protein is detectable in the blastula (stage 9), whereas 
HNF1α protein  is not detected until the hatched larvae (stage 35), even though HNF1α 
transcription  starts in the gastrula (stage 11) (Pogge v.Strandmann et al., 1997). It seems 
likely that HNF1β acts initially through the HNF1 binding site of HNF1α promoter to affect 
the accumulation of HNF1α transcripts in Xenopus (Weber et al., 1996; Pogge 
v.Strandmann et al., 1997). 
2.3 Phenotype of HNF1 homozygous knockout mice 
In agreement with the differential embryonic expression patterns of the two HNF1 proteins, 
inactivation of the corresponding genes in the mouse has different effects. Homozygous 
knockout of the HNF1β gene leads to early embryonic lethality at day 7.5 due to abnormal 
extraembryonic development, including poorly organized extraembryonic ectoderm as well 
as defective differentiation of the parietal and visceral endoderm (VE) of the yolk sac. 
(Barbacci et al., 1999; Coffinier et al., 1999b). The VE serves as a source of nutrients and 
multiple signals essential for normal development of the pregastrulating mouse embryo. In 
addition to its nutritional and histotrophic role, the VE participates in other embryonic 
developmental processes including early anterior neural patterning (Beddington and 
Robertson, 1998), cavitation of the ectoderm (Coucouvanis and Martin, 1999), and 
specification of hematopoietic and endothelial cell fates (Belaoussoff et al., 1998). HNF1β 
homozygous mutant embryos lack a distinct extraembryonic VE, and as a consequence, the 
extraembryonic ectodermal cells are severely disorganized. The early embryonic lethality 
in mice with homologous inactivation of the HNF1β gene has precluded further analysis of 
the functions of this gene later in development.  
To circumvent early lethality, site-specific inactivation and knock-down strategies have 
been used for HNF1β in two recent studies. HNF1β was specifically inactivated in renal 
cells using the Cre-loxP strategy (Gresh et al., 2004). The KspCre transgenic mouse  
expressing the Cre recombinase under the control of the Ksp-cadherin (Cadherin 16) 
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promoter was used to restrict the inactivation to renal cells.  Inactivation of the HNF1β 
gene was achieved by generating mice carrying a homozygous floxed HNF1β gene together 
with the KspCre transgene (Coffinier et al., 2002). Mice with renal-specific inactivation of 
HNF1β developed polycystic kidney disease via a drastic reduction of Umod, Pkhd1 and 
Pkd2 gene expression. Mutations in these genes have also been shown to cause other 
distinct cystic kidney syndromes (Kudo et al., 2004; Bergmann et al., 2004; Wu et al., 
2002). The A263insGG mutant of HNF1β functions as a dominant-negative mutant when 
expressed in liver, pancreatic, and kidney cell lines (Tomura et al., 1999; Bohn et al., 2003). 
Expression of this mutant in transgenic mice under the control of a kidney-specific 
promoter led to the development of renal cysts and renal failure, similar to humans carrying 
the A263insGG mutation. The DN-HNF1β mutant protein dimerizes with WT HNF-1β, 
inhibiting binding to and activation of the Pkhd1 promoter (Hiesberger et al., 2004). Taken 
together, these data strongly support a role for HNF1β during nephrogenesis in mice.  
In contrast, HNF1α is not required for early embryonic development. Defects caused by 
knockout of HNF1α in mice only manifested themselves after birth. These defects included 
hepatomegaly, phenylketonuria and Fanconi syndrome, and the mice die during postnatal 
life because of hepatic, pancreatic and renal dysfunction (Pontoglio et al., 1996; Pontoglio 
et al., 1998; Lee et al., 1998). A more detailed analysis revealed defective insulin secretion 
in the pancreatic β-cells in HNF1α-deficient mice (Dukes et al., 1998; Pontoglio et al., 
1998; Pontoglio, 2000). The differences in the phenotypes of HNF1α- and HNF1β-
knockout mice clearly establish differential roles for these genes, but do not directly reveal 
whether this functional difference reflects differential properties of the two transcription 
factors or rather differential expression patterns. Addressing this issue, a functional 
equivalence of the α and β proteins has been recently been shown in embryonic stem cells. 
Expression of HNF1α in HNF1β-deficient stem cells fully restored their ability to 
differentiate into mature visceral endoderm (Haumaitre et al., 2003).  
2.4 Heterozygous mutations in HNF1 genes cause MODY in humans. 
In contrast to the mice with heterozygous mutations in HNF1 genes had no phenotype,  
heterozygous mutations in HNF1 genes cause MODY in humans (Barbacci et al., 1999; 
Pontoglio et al., 1998). Maturity onset diabetes of the young (MODY) is an autosomal 
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dominant inherited disease in humans that is characterized by an early onset of non-insulin 
dependent diabetes mellitus (NIDDM) (recent reviews: (Hattersley, 1998; Froguel and 
Velho, 1999; Winter et al., 1999; Winter and Silverstein, 2000). This disease manifests 
itself clinically by the occurrence of diabetes in at least two generations with at least one 
member affected under the age of 25 years, and is caused by defective insulin secretion of 
the β-cells of the pancreas. To date, heterozygous mutations in five genes have been 
associated with this disease in humans. Except for the MODY2 gene, which encodes the 
glucokinase enzyme expressed in the β-cells, all the other MODY genes identified encode 
cell-specific transcription factors expressed in pancreatic β-cells. MODY4 represents 
mutations in the gene encoding the transcription factor IPF-1 (insulin promoter factor-1), 
also referred to as PDX-1 (pancreatic duodenal homeobox-1), IDX-1 (islet duodenal 
homeobox-1) or STF-1 (somatostatin transcription factor-1), that was initially identified as 
a transcription factor necessary for pancreatic development and islet peptide hormone 
expression (Habener and Stoffers, 1998). In contrast, MODY1, MODY3 and MODY5 are 
genes for HNF4α, HNF1α and HNF1β, respectively (Huang and Tsai, 2000).  
Additionally, HNF1β mutations are associated with severe non-diabetic renal defects, 
pancreatic atrophy as well as genital malformations in females (Eeckhoute et al., 2003; 
Briancon et al., 2004; Ryffel, 2001). These renal defects are distinct from the diabetic 
nephropathy frequently occurring in MODY3 patients due to microvascular complications 
in the kidney leading to progressive microalbuminuria, macroalbuminuria and renal failure 
strongly correlated with poor glycemic control (Isomaa et al. 1998). Patients with HNF1β 
mutations are born with renal defects, and a defective kidney has even been observed in a 
17-week-old fetus carrying a heterozyous mutation in HNF1β (Bingham et al., 2000), 
suggesting that HNF1β dysfunction interferes with kidney organogenesis. This assumption 
was confirmed by overexpression of HNF1β in Xenopus embryos (Wild et al., 2000). 
Overexpression of HNF1β induced severe defects in pronephros, the first type of kidney to 
develop in vertebrates. This effect was specific, as overexpression of HNF1α did not affect 
any phase of kidney organogenesis. Together these results indicate that different intrinsic 
biochemical properties of these two transcription factors mediate the HNF1β-specific 
effects in nephrogenesis.  
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3. The Xenopus pronephros is a model system for studying kidney 
development. 
3.1 Xenopus laevis as a model system 
Xenopus laevis, commonly called the South African clawed frog due to the presence of 
claws on the three inner toes of the hind feet, has been used extensively as a non-
mammalian model not only for vertebrate embryology, but also for research in the areas of 
cellular biology, physiology and biochemistry. The Xenopus embryo is a good system to 
study embryonic development because early development occurs outside of the mother, the 
eggs and embryos are relatively large, the blastomeres determined to become specific 
structures are readily identifiable and the embryo can withstand extensive surgical 
intervention as well as survive in vitro culture. The animals can be housed in a laboratory 
with minimal infrastructure. Thousands of eggs can be collected after priming egg ripening 
by injection of chorionic gonatropin into the lymph sac. Finally, development can be 
synchronized by fertilizing batches of eggs in vitro, so that groups of embryos are obtained 
at a defined stage of embryonic development (Sive et al., 2000; Olive et al., 2003; Ryffel, 
2003). Xenopus embryos develop rapidly after fertilization, producing tadpoles with fully 
functional organs within 2-3 days, depending on temperature. The embryos develop well in 
a simple low-salt solution, and the larvae do not require feeding. Embryogenesis and, 
especially organogenesis, can easily be monitored in vivo, as the larvae are quite 
transparent. This allows the uninvasive examination of embryos after experimental 
manipulation.  
Surgical manipulations performed in Xenopus embryos included the explantation of a 
defined region of the embryo as well as the injection of RNA or DNA into specific 
blastomeres. The mRNA for a specific gene can be injected into the fertilized egg or into 
blastomeres of early cleaving stages (Sive et al., 2000) to produce an efficient 
overexpression of the protein targeted to a specific region of the embryo. The injection can 
also be restricted to one side of the embryo by injection into one blastomere at the 2-cell 
stage, allowing the use of the uninjected side as a control within the same animal. 
Additionally, the localized expression of an exogenous mRNA can be controlled by 
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coinjecting mRNA or cDNA for a suitable lineage marker such as β-galactosidase or green 
fluorescent protein. Alternatively, the expression of a protein can be knocked down through 
injection of a morpholino antisence oligonucleotides. Native gene expression can be 
measured via RT-PCR of isolated RNA from whole embryos or embryonic areas. Finally, 
all of these manipulations can be carried out at the specific developmental stage of interest 
after embryo manipulation. 
3.2 The pronephros as a model system for kidney development 
Three distinct types of kidneys develop progressively after one another in vertebrates. The 
pronephros forms first during early larval development, followed by the mesonephros or 
middle kidney, and lastly the metanephros which is also the functional kidney in the adult. 
They have a similar functional organization and differ primarily in their spatial organization 
and complexity. The functional unit of every kidney type is the nephron. Later kidney types 
contain more and more complexly organized nephrons.  
Similar regulatory genes are expressed during the development of all three kidney types, 
indicating that the molecular processes controlling the development of the different kidneys 
are closely related (Jones, 2003; Vize et al., 2003). Many of the gene products identified in 
the developing Xenopus pronephros have also been shown to play eminent roles in the 
development of the vertebrate meso- and metanephros. The simplicity of the structure as 
well as the parallels that can be drawn for gene function in the more complex vertebrate 
kidneys make the Xenopus pronephros a good model system for the study of kidney 
development. 
The pronephros is the simplest vertebrate kidney, and consists of a single nephron with an 
external glomus. The basic structure of the Xenopus pronephros is illustrated in figure 2. 
The glomus freely filters wastes into the nephrocoel or coelom. The fluid of the coelom is 
taken up by three ciliated funnels (nephrostomes) that are joined into the coiled pronephric 
tubule (consist of connecting and common tubules). The common tubule is highly 
convoluted and surrounded by blood vessels into which water and small molecules that are 
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Figure 2. The Xenopus pronephros. The basic structure of the pronephros 
is shown schematically. Glomus, tubule and duct tissues are shown in green, red 
and blue, respectively. For further details see (Vize et al., 1997; Brändli, 1999). 
not to be excreted are collected. The concentrated waste is then disposed of via the 
pronephric duct through the cloaca. 
The pronephros develops from the somatic and splanchnic layers of intermediate 
mesoderm, and its development is completed within five days. The region determined to 
become the pronephros can be identified in the early neurula stage (stage 12/13). The first 
morphological indication of pronephric development is observed in the late neurula stage 
(stage 20/21) as a thickening of the somatic portion of the lateral mesoderm below somites 
3 through 5. This thickening is caused by a cellular shape change as the pronephric 
precursor cells become columnar. In the tailbud embryo (stage 24), this thickening extends 
posteriorly to somite 6, and the cells can be seen to be assembling into a compact 
aggregate, forming the pronephric anlage (Hausen and Ribesel, 1991; Nieuwkoop and 
Faber, 1975). The anlage is subdivided into the tubules and duct during tadpole 
development (stages 30 to 38). At this time the third pronephric compartment, the glomus, 
develops from the splanchnic mesoderm which lines the coelom (Bernardini et al., 1999). 
The pronephric tubules can be easily identified in the living larvae, but the duct and glomus 
can only be visualized in the whole embryo after staining for specific markers using either 
specific antibodies or hybridization probes. The Xenopus pronephros has been described in 
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detail using such techniques, and excellent reviews are available (Carroll et al., 1999; Vize 
et al., 1997; Brändli, 1999). 
3.3 lim1, Pax8 and HNF1β in pronephric development 
The transcription factors, lim1, Pax8 and HNF1β play important roles in pronephric 
induction, pattering and differentiation. The earliest marker of pronephric specification in 
early development is lim1, which is expressed at the late gastrula stage, concomitant with 
the time at which the specification of tubules is occurring. Treatment of animal caps 
derived from blastula stage embryos with either activin or retinoic acid results in the 
expression of lim1 in the animal cap tissue (Taira et al., 1994; Uchiyama et al., 1996). It has 
been demonstrated that such treatment of animal caps results in the histological and 
immunohistological identification of pronephric tubules (Uchiyama et al., 1996; Brennan et 
al., 1999). lim1 overexpression following the injection of synthetic mRNA into early 
embryos, however, is insufficient to cause a high frequency of ectopic kidney formation, 
although there is synergism between lim1 and pax8 in kidney development following 
coinjection (Taira et al., 1994; Carroll and Vize, 1999). Furthermore, injection of wild-type 
or constitutively active lim1 in both activin- and RA-treated caps, augmented pronephric 
formation was observed. In contrast, when a dominant-negative lim1-eng was injected, this 
inhibited differentiation of the pronephros by 25-75%. Studies of targeted overexpression in 
whole tadpoles showed that a functional deficiency in lim1 resulted in a failure of the 
pronephros to undergo tubulogenesis (Chan et al., 2000). These studies suggest that lim1, 
although an important regular of pronephric tubule development, is unable to induce 
pronephros independently, suggesting that there are other molecules that are involved in 
formation of the pronephric primordium. 
The Pax8 protein has also been shown to play a role in the development of the pronephros. 
Pax8 expression is detected at late gastrulation in both the otic vesicles and the presumptive 
pronephros (Carroll and Vize, 1999). The timing of pronephric expression of Pax8 
coincides absolutely with the time at which the pronephros is specified. Injection of 
synthetic Pax8 mRNA alone targeted into the C2 blastomere of the 32 cell embryo has been 
shown to lead to the development of either enlarged or ectopic pronephroi. Further 
experiments have shown dramatically that lim1 can synthegize with Pax8 to generate 
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ectopic kidney (Carroll and Vize, 1999). Another Pax genes implicated in the control of 
kidney development, Pax2, was also capable of causing the same effects as Pax8 when 
coinjected with lim1, showing that Pax8 and Pax2 are functionally redundant in Xenopus 
(Carroll and Vize, 1999). These experiments suggest that lim1 and Pax8 are certainly 
important regulators of tubulogenesis. 
HNF1β is also expressed in this region at the same time as lim1 and Pax8.  Overexpression 
of human HNF1β in Xenopus embryos led to defective development and agenesis of the 
pronephros (Wild et al., 2000). A similar phenotype is seen after the expression of certain 
mutants of the human HNF1β gene, that have been linked with kidney disease. The 
expression of other HNF1β mutant proteins resulted in an enlargement of the pronephors 
(Wild et al., 2000; Bohn et al., 2003). Together, these data indicate that HNF1β, lim1 and 
Pax8 are the earliest regulators in the pronephric anlage, and may cooperate in the early 
events of nephrogenesis. 
4. Aim of this work 
As only the HNF1β protein has an effect on pronephric development, the aim of this work 
was to identify the protein domains of HNF1β that are specifically involved in pronephric 
development. To this end, mutant and chimeric HNFα and HNF1β proteins were expressed 
in Xenopus embryos as well as in mammalian cell lines. The functionality of these proteins 
was analyzed by examining their subcellular localization and transactivation potential in 
HeLa cells, as well as their effect on pronephric development after expression in Xenopus 
embryos. In an effort to evaluate the cooperation of HNF1β with lim1 and Pax8, all three 
transcription factors were coinjected into Xenopus embryos. Specifically, whether HNF1β 
could rescue lim1/Pax8-induced malformations of the pronephros was examined. 
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II. Materials and Methods 
1. Chemicals and enzymes 
The chemicals used in these experiments were obtained either from Fluka (Neu-Ulm), 
Merck (Darmstadt), Roth (Karlsruhe), Serva (Heidelberg) or Sigma-Aldrich (Taufkirchen) 
when sources are not specifically named in the text. Solutions and buffers were prepared as 
previously described (Sambrook et al., 1989). Restriction enzymes and enzymes for 
modifying DNA und RNA were purchased from Biolabs (Schwalbach), Invitrogen 
(Karlsruhe), Pharmacia (Freiburg) und Roche (Mannheim) when sources are not 
specifically named. All primers employed for PCR were synthesized by Invitrogen 
(Karlsruhe). 
2. Molecular cloning and expression vectors 
DNA techniques including the preparation of competent cells, plasmid DNA, in vitro 
amplification of DNA using the polymerase chain reaction (PCR), and electrophoresis were 
carried out as previously described in standard molecular biology technique collections 
(Sambrook et al., 1989). Preparation of large quantities of plasmid DNA was carried out 
using the Qiagen “Plasmid Maxi Kit” (Hilden) according to the supplied protocol. 
2.1 Plasmid Constructions 
The expression plasmids pCSGFP2, myc-Rc/CMVHNF1β (HNF1β) and myc- 
Rc/CMVHNF1α (HNF1α) have been described elsewhere (Wild et al., 2000). The 
expression construct for Xenopus HNF1β (XHNF1β) was kindly provided by Roberto 
Vignali (Vignali et al., 2000). Expression plasmids for Xenopus lim1 and Pax8 were kindly 
supplied by Peter D.Vize (Carroll and Vize, 1999). The syn(0)4tk-luc reporter plasmid used 
in transfection assays contains four HNF1 binding sites upstream to a thymidine kinase 
promoter and the luciferase gene (Drewes et al., 1996). All fragments generated by PCR for 
cloning were verified by sequencing. 
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All HNF1β variants listed in Table 1 were inserted into two expression vectors. The 
Rc/CMVGFP vector was used for transfection in HeLa cells. The pCS2+MT vector, 
containing six Myc tags at the 5’-end of the first polylinker, was used for overexpression in 
Xenopus embryos (Rupp et al., 1994). The coding region of GFP was amplified by PCR 
from the plasmid pCSGFP2 plasmid. The GFPFw sense primer contains a HindIII 
restriction site, and the GFPRe antisense primer contains an EcoRI restriction site. The PCR 
fragment was double digested with HindIII-EcoRI, and cloned into the HindIII-EcoRI sites 
of Rc/CMV (Invitrogen).  
HNF1aaa was generated by ligating the EcoRI-BamHI and BamHI-XbaI PCR fragments 
encoding 1-69 aa and 70-321 aa of HNF1α amplified with the primers listed in Table 1. 
HNF1bbb was generated by ligating the EcoRI-BamHI and BamHI-XbaI PCR fragments 
encoding amino acids 1-79 aa and 80-352 aa of HNF1β using the primers listed in Table 1. 
A BamHI site was introduced both at G69 (α) and G79 (β) without changing the predicted 
amino acid sequence. The EcoRI and XbaI restriction sites were generated immediately 
upstream to the translational starts and immediately to the translational 3' stops using PCR, 
respectively.  
The HNF1abb chimera was generated by ligating the EcoRI-BamHI PCR fragment 
encoding 1-69 aa of HNF1α and the BamHI-XbaI fragment encoding 80-352 aa of HNF1β. 
The HNF1baa chimera was generated by ligating the EcoRI-BamHI PCR fragment 
encoding 1-79 aa of HNF1β and the BamHI-XbaI fragment encoding 70-321 aa of HNF1α. 
HNF1bbbD was generated by constructing a primer containing sequence areas 
complementary to regions upstream and downstream of the cDNA sequence encoding the 
26 aa segment to be deleted, but lacking the segment transcribing the 26 aa itself.  The PCR 
fragment generated was consequently lacking the 26 aa segment coding region. The 
fragment was digested with BamHI and HincII, then inserted into the BamHI-HincII sites of 
HNF1bbb. HNF1βD was generated by replacing the PvuI fragment coding for 1-251 aa of 
HNF1β with the corresponding fragment from  HNF1bbbD containing the 26 aa deletion. 
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Table 1. Constructs created for use in expression vectors. Restriction enzyme sites included 
in the primers are underlined.  
Name Primer sequences (5’-3’) Protein fragment encoded 
HNF1aaa 
α1-69Fw: CGGAATTCAATGGTTTCTAAACTGAGCC  
α1-69Re: CGCGGATCCCCGAGTCTCCCCC
 α70-321Fw: CGCGGATCCGAGGACGAGACGG 
α70-321Re: GCTCTAGATTAGCGCACACCGTGGAC
 
 
HNF1α, 1-321aa 
 
HNF1bbb 
β1-79Fw: CGGAATTCAATGGTGTCCAAGCTCACGT 
β1-79Re: CGCGGATCCCTCGTCGCCGGACAA
 β80-352Fw: CGCGGATCCGAGGACGGCGACGA 
β80-352Re: GCTCTAGATTAGCGCACTCCTGACAGC
 
 
HNF1β, 1-352aa 
 
HNF1abb α1-69Fw,
 
α1-69Re; β80-352Fw, β80-352Re HNF1α, 1-69aa HNF1β, 80-352aa 
HNF1baa β1-79Fw,
 
β1-79Re; α70-321Fw, β70-321Re HNF1β, 1-79aa HNF1α, 70-321aa 
HNF1bbbD 
β80-211Fw: CGCGGATCCGAGGACGGCGACGA 
 β80-211del183-208aaRe: 
GCTCTGTTGACTGAATTGTCGGAGGATCTCTCGT
 
HNF1β, 1-352aa with 
a deletion of 183-
208aa 
HNF1βD  
HNF1β, 1-557aa with 
a deletion of 183-
208aa
 
HNF1βhomeo 
β229-352Fw: CGGAATTCAAAGAAGATGCGCCGCAAC, β80-
352Re
 
HNF1β, 229-352aa 
 
HNF1aab 
β229-352Fw: GATGAGCTACCAACCAAGAAGATGCGCCGCA
 β229-352Re: GCCGCTCTAGATTAGCGCACTC
 
HNF1α, 1-196aa 
HNF1β, 229-352aa 
HNF1aabins26 
β183-352Fw: 
CGAGAGGTGGCGCAGCAGTTCAACCAGACAGTCCAG
 β229-352Re
 
HNF1α, 1-176aa 
HNF1β, 183-352aa 
HNF1aaains26 
β183-208Fr: 
CGAGAGGTGGCGCAGCAGTTCAACCAGACAGTCCAG 
β183-208Re: 
CTCCCTGCCCTGCATGGGTGAACTCTGGAAAGAGAAAC
 
HNF1α, 1-321aa with 
an insertion of 
HNF1β, 183-208aa at 
176 aa of HNF1α 
HNF1aabH 
α70-196Fw: CGGAATTCAATGGTGTCCAAGCTCACGT
 β229-319Re: GCTCTAGATTAGCTATAGGCGTCCATGG
 
HNF1α, 1-196aa 
HNF1β, 229-319aa 
HNF1aabHS 
α70-196Fw,
 β229-311Re: GCTCTAGATTATTGCCGGAATGCCTCCT
 
HNF1α, 1-196aa 
HNF1β, 229-311aa 
Rc/CMVGFP GFPFw: GGCAAGCTTCTGGCCACCATGAGTAAAGGA
 GFPRe:  CGGAATTCGTTTTGTATAGTTCATCCATGC
 
GFP, 1-238aa to 
create GFP-fusion 
protein expression 
vector 
 
The HNF1aab, HNF1aabins26 and HNF1aaains26 chimeras were generated by site-directed 
mutagenesis using the Quickchange site-directed Mutagenensis Kit (Stratagene, La Jolla, 
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CA) with pairs of complementary mutagenic primers. These mutagenic primers were the 
PCR products encoding 229-352 aa, 183-352 aa and 183-208 aa of HNF1β, respectively. 
The HNF1aaa construct was used as a template for the mutagenesis.  
The HNF1aabH and HNF1aabHS constructs were generated by replacing the BamHI-XbaI 
fragment from HNF1aab with PCR products encoding either 70-319 aa or 70-311 aa of 
d in transiently transfected HeLa 
cells. Expression vectors encoding various HNF1 fusion proteins were cotransfected 
nted 
culture medium into each 3.3 cm cell culture well, and incubated overnight at 37°C and 5% 
HNF1abb, respectively, using the primers listed in Table 1. 
3. Functional protein studies in HeLa cells 
The transactivition activity of HNF1 proteins were assaye
together with a luciferase reporter plasmid. The HeLa cell line (derived from a human 
cervical carcinoma) was cultured at 37°C, 7.2% CO2 and 95% humidity in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with penicillin (100U/ml), streptomycin 
(100U/ml), 2 mM L-glutamine, and 10% heat-inactivated fetal calf serum (Biochrom). 
The day before transfection, 3 x 105 HeLa cells were seeded with 3 ml of suppleme
CO2. The cells were 50-80% confluent 24 h after seeding. For the luciferase assay, the cells 
in one well were transiently transfected with 1.3 µg reporter plasmid, 0.3 µg expression 
vector and 6µl of lipofectamine (Invitrogen, Carlsbad, CA). The total DNA concentration 
per well was equalized by the addition of Rc/CMV vector where necessary. Additionally, 
the subcellular localization of GFP-HNF1 fusion proteins was examined after transient 
transfection with 1µg expression vector into HeLa cells. The cells were rinsed once with 
Optimem (Gibcol, ) and overlayed with the diluted DNA-liposome complex solution, then 
incubated at 37°C and 5% CO2 for 4 h. The culture medium was replaced with fresh 
DMEM after transfection, and the transfected cells were cultured an additional 20 h. The 
growth medium was removed from the transfected cell wells, and cells were rinsed twice 
with PBS. For the luciferase assay, cells were lysed in 50µl of lysis buffer (25 mM tris-
phosphate (pH 7.8), 2 mM DTT, 2 mM CDTA, 10% glycerol, 1% triton X-100). After 
incubating 5 minutes at room temperature, the attached cells were scraped free from the 
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culture dish. The lysed cells were transferred to a microcentrifuge tube, and centrifuged at 
4°C for 5 min at 13,000 RPM to pellet the cell debris. The supernatent (cell extract) was 
transferred to a new tube, and the transactivation activity was measured using the luciferase 
reporter assay system (Promega, Madison, WI) in a Lumat LB 9501 luminometer 
(Berthold, Wilbad, Germany) according to the manufacturer’s directions. For the 
subcellular localization, the cells were analyzed using fluorescence microscopy (Leica, 
Köln) 
4. Xenopus embryos 
pus embryos 
Adult Xenopus laevis frogs were purchased from distributors Xenopus 1 (USA),  and 
maintained in the Institute for Cell Biology (Essen) according to animal care regulations. 
4.1 Manipulation of Xeno
Adult female frogs were injected in the dorsal lymph sac with 200-250 IU (depending on 
the individual size) of human chorionic gonadotropin (hCG, Serono Pharma GmbH, 
Unterschleißheim). Injected frogs were kept overnight at room temperature. The frogs 
began to lay eggs 9-10 h later. A male frog was first anesthesized by submerging it in 0.5% 
MS-222 for 20 min before sacrificing it and dissecting out the testes. The testes was kept up 
to 10 days at 4°C in a humidity chamber. A piece was washed with Holtfreter’s solution (60 
mM NaCl, 0.6 mM KCl, 0.9 mM CaCl2, 0.2 mM NaHCO3), then rubbed over the Xenopus 
eggs. The fertilized eggs were flooded with water. Within 20 min, the eggs rotated so that 
the animal pole was up, indicating that fertilization had occurred. The jelly coat was 
removed from the embryos by swirling gently in 0.1 × Marcs modified Ringer’s solution 
(MMR: 0.1 M NaCl, 2 mM KCl, 1 mM MgSO4, 2 mM CaCl2, 5 mM HEPES (pH 7.8), 0.1 
mM EDTA) containing 2% cysteine (Fluka) at pH 8.0 for 1-2 min until the jelly coats were 
no longer surrounding the egg. The fertilized eggs were rinsed at least 5 times with water, 
then incubated in 0.1x MMR at 14-20ºC until the desired stage. The developmental stages 
were assigned according to the Xenopus laevis development table from Nieuwkoop and 
Faber (Nieuwkoop and Faber, 1975). 
 
Materials and Methods   
 
20
4.2 In vitro mRNA synthesis  
For overexpression in Xenopus, mRNA was synthesized in vitro following the protocol 
from Nielsen and Shapiro (1986). The expression vector (3µg) was linearized, then 100 
units RNA polymerase were used for each in vitro transcription reaction. Expression 
constructs in the pCS2 vector were digested with NotI, and pCSGFP2 plasmid was 
linearized with PvuII, then purified by extraction with phenol:chloroform using the Phase 
Lock GelTM Light (1.5ml, Eppendorf) according to the manufacturer’s directions. All 
expression constructs in the pCS2 vector were transcribed using SP6 RNA polymerase. The 
expression constructs in the Rc/CMV vector were linearized with SmaI (25°C, 1 h), and 
transcribed using T7 RNA polymerase (Nielsen and Shapiro, 1986). After in vitro 
transcription, Rnase-free DNase I was added to destroy the template DNA (37°C, 15 min). 
The RNA was purified by extraction with phenol:chloroform using the Phase Lock GelTM 
Heavy (1.5ml, Eppendorf) according to the manufacturer’s directions. The aqueous phase 
was transferred to a fresh microfuge tube, and 2.5 volumes of ethanol were added. The 
precipitated RNA was stored in ethanol in 20µl aliquots at –80°C. The RNA concentration 
was measured by a photometer (Abs260) and the RNA quality was controlled by gel 
electrophoresis. 
4.3 Microinjection 
Prior to injection, mRNA was precipitated and dissolved in DEPC-treated water. Either 
250pg mRNA encoding a protein together with 100pg GFP mRNA or 350pg GFP mRNA 
alone was injected in a volume of 10µl. Capped and tailed mRNA was microinjected into 
one blastomere of 2-cell stage Xenopus embryos using glass microcapillaries (ø 0.59mm, 
World precision instruments, Sarasota) and a micromanipulator (Gernaral valve 
corporation, Fairfield). Embryos were kept in 2% Ficoll 400 in 0.1× MMR during 
microinjection, and for 1 h following the injection to facilitate plasma membrane sealing. 
Embryos were cultured in 0.1 x MMR at 20ºC until the desired stage was reached. 
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5. Immunohistochemistry 
Xenopus embryos expressing HNF1 proteins were examined for pronephric defects at stage 
44-45 after immunohischemical staining for kidney markers. The tadpoles were fixed 1 h in 
MEMFA (0.1 M MOPS (pH 7.4), 2 mM EGTA, 1 mM MgSO4, 3.7% formaldehyde), then 
dehydrated in methanol overnight at 4ºC. Embryos were subsequently rehydrated in PBS, 
then  blocked 15 min with PBT (2 mg/ml BSA (bovine serum albumin, fraction V) and 
0.1% Triton X-100 in PBS) at room temperature. The embryos were incubated overnight at 
4°C with a 1:2 dilution of the pronephric tubule-specific 3G8 antibody and the duct-specific 
4A6 antibody in PTB containing 20% goat serum (Vize et al., 1995). These antibodies were 
kindly provided by Elisabeth A. Oliver-Jones (Warwick University, Coventry, UK 
Coventry, England). After washing 5 times with PBT at room temperature, the embryos 
were incubated overnight at 4°C with Cy3-conjugated rat anti-mouse antibody diluted 
1:1000 (Jackson ImmunoResearch, Pennsylvania, USA). Embryos were washed twice with 
PBT at room temperature, then analyzed using fluorescence microscopy (Leica, Köln).   
6. Phenotype analysis 
The phenotypic effects of overexpression were analyzed by comparing the injected and  
uninjected sides of stage 44-45 embryos. The areas through the widest part of the 
immunostained pronephros containing the pronephric tubules and through the anterior part 
of the pronephric duct were measured using the Kappa Metreo computer program (opto-
electronics GmbH, Gleichen). No size difference between the injected and uninjected sides 
was set as 100. When it is over 100, the size of the pronephros in injected side is enlarged; 
while it is below 100, that is smaller. The Mann-Whitney test was used to compare the 
measurements obtained from each group of embryos with GFP control-injected embryos. 
Each group contained at least 30 embryos.  
7. Western blotting 
Embryonic lysates were prepared by homogenizing microinjected embryos cultured until 
stage 10 or later (60 embryos per 200 µl of lysis buffer (50 mM Tris (pH 7.9), 25% (v/v) 
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glycerol, 50 mM KCl, 2mM DTT, 0.1 mM EDTA, 0.1mM benzamidine, 0.1mM PMSF, 
1µg/µl leupeptin and 1µg/µl pepstatin). Embryo lysates were pre-cleared by centrifugation 
at 15,000 RPM for 15 min at 4˚C (Beckmann TL-100 Ultracentrifuge). The total protein 
concentration was measured using the “BioRad Protein-Assay” system (BioRad ). The 
lysates were combined with 1/3 volume SDS sample buffer (187.5 mM Tris-HCl (pH 6.8), 
6% SDS, 3% glycerol, 0.03% phenol red and 125 mM DTT), boiled 3 min, resolved by 
15% SDS-PAGE, and electroblotted at 1.5 mA/cm onto nitrocellulose membrane 
(Schleicher and Schuell, Dassel) using the Trans-Blot SD Electrophoretic Transfer Cell 
(BioRad) in transfer buffer (48 mM Tris, 39 mM glycine, 0.04% SDS, 20% methanol). The 
membrane was blocked with 0.5% blocking reagent (Liquid block, RPN 3601, Amersham, 
Braunschweig) in PBS at 4°C overnight, then incubated 90 min with the GE10 anti-myc 
monoclonal antibody (Evan et al., 1985) diluted 1:5 in PBS containing 0.1% Tween 20. 
After washing 3 x 10 min with 0.1% Tween 20 in PBS, the membrane was incubated for 1 
h with peroxidase-conjugated rabbit anti-mouse antibody (Dianova) diluted 1:5000 in wash 
buffer. The membrane was washed 3 times, then the secondary antibody was detected using 
the Enhanced Chemoluminescence System (ECL-System, Amersham) according to 
manufacture’s instructions. All steps were carried out at room temperature unless otherwise 
specified. 
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III. Results 
1. The functionality of the GFP-HNF1β fusion protein  
1.1 The GFP-HNF1β fusion protein has similar localization and transactivation    
properties as HNF1β in transfected HeLa cells. 
Creation of a GFP-HNF1β fusion construct eliminated the necessity of coinjecting a marker 
into the injected side, and allowed the analysis of HNF1β function in cells and Xenopus 
embryos. The GFP-HNF1β construct was generated by inserting the coding sequence for 
GFP upstream to the HNF1β coding sequence. The pCS2 expression vector was more 
efficient for producing the protein in HeLa cells as well as Xenopus embryos than the 
Rc/CMV vector (data not shown). These expression vectors use different promoters and 3′ 
untranslated regions, which have an influence on mRNA stability and protein expression 
level. For this reason, the myc-tagged constructs were subcloned into pCS2 vector for 
injection into Xenopus embryos. The Rc/CMV vector was adequate for transfection assays 
in HeLa cells. The GFP-HNF1β fusion protein construct was transiently transfected into 
HeLa cells to show that the fusion protein is localized in the correct subcellular 
compartment to be functional. As has been shown previous for the native HNF1β protein, 
GFP-HNF1β was localized exclusively in the nuclei of transfected HeLa cells (Figure 3A) 
(Bohn et al., 2003). As a comparison, GFP was expressed both in the nucleus and 
cytoplasm of transfected HeLa cells (Figure 3A). These results indicate that the attached 
GFP domain does not influence the nuclear translocation of the HNF1β protein. To explore 
the transactivation potential of GFP-HNF1β, expression vectors encoding myc-HNF1β or 
GFP-HNF1β were cotransfected into HeLa cells lacking endogenous HNF1α and β 
expression together with a luciferase reporter plasmid containing an HNF1-inducible 
promoter. Figure 3B shows that equivalent amounts of either the GFP-HNF1β or myc-
HNF1β constructs similarly transactivated the luciferase reporter in a dose-dependent 
manner. The results indicate that the GFP-HNF1β fusion protein functions similarly to the 
myc-HNF1β fusion protein in transfected cells. It has been shown previously that the myc-
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HNF1β fusion protein behaves similarly to the native HNF1β protein (Wild et al., 2000), 
implying that the GFP-HNF1β fusion protein is functionally equivalent to native HNF1β. 
 
 
Figure 3. Subcellular localization and transactivation potential of GFP-HNF1β fusion construct. (A) 
HeLa cells expressing GFP or GFP-HNF1β fusion construct illuminated by bright field or green fluorescence. 
bar = 10µm. (B) Increasing amounts (5, 10, 30, 50, 150, 300ng) of GFP-HNF1β or myc-HNF1β were 
cotransfected into HeLa cells with an HNF1-dependent luciferase reporter plasmid. The fold-activation 
induced by each of the HNF1β expression constructs is shown. Error bars indicate standard deviation of the 
mean of at least six replicates. 
1.2 Expression of the GFP-HNF1β fusion protein interferes with nephrogenesis in 
Xenopus embryos.  
In order to analyze the function of HNF1β during nephrogenesis, the GFP-HNF1β fusion 
protein was overexpressed in the Xenopus embryos. The GFP-HNF1β mRNA was injected 
into one blastomere at the 2-cell stage of Xenopus embryos. As a comparison, GFP mRNA 
was coinjected with RNA encoding myc-tagged HNF1β. At the neurula stage, embryos 
were selected with strong GFP fluorescence restricted to only one side, and sorted into 
groups injected in either the right or left sides (Figure 4). The embryos injected with GFP 
mRNA and myc-tagged HNF1β showed very strong fluorescence at the initial tail bud 
stage (Figure 4A), and continued to fluoresce into the larval stage (Figure 4B). Embryos 
injected with GFP-HNF1β mRNA fluoresced more weakly at the initial tail bud stage 
(Figure 4C), and no fluorescence was observed at later stages. Strong GFP fluorescence 
was only observed in 10% (29/295) of embryos overexpressing GFP-HNF1β, as compared 
with 86% (259/300) of the embryos coinjected with myc-HNF1β and GFP mRNA (Figure 
6). Some GFP-HNF1β-injected embryos exhibited strong enough fluorescence to see that 
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the fusion protein was expressed in a spotted pattern, representing a nuclear expression 
pattern that was never observed for injected GFP mRNA. Although expression indicated 
that the GFP-HNF1β fusion protein was functional, the reduced level of the fluorescence 
especially at later stages made it inadequate for phenotypic analysis in a whole embryo.  
 
 
Figure 4. Expression of GFP alone or the GFP-HNF1β fusion protein in Xenopus embryos. (A)  Lateral 
view of a typical larva (stage 23) expressing GFP on the left side. bar = 150m. (B) Lateral view of a typical 
larva (stage 39) expressing GFP on the right side. bar = 1mm. (C) Lateral view of a typical larva (stage 21) 
expressing GFP-HNF1β on the right side. bar = 300µm. (D) Lateral view of a typical larvae (stage 21) 
expressing GFP-HNF1β on the right side showing spotted GFP fluorescence pattern representing nuclear 
expression. bar = 300µm. Both uninjected and injected sides of each larva are shown, and the injected sides 
are marked by white stars. 
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Figure 5. Expression of the HNF1β protein in Xenopus reduces kidney size.  (A) Dorsal and lateral view 
of a larva (stage 44-45) expressing the HNF1β protein. Whole-mount immunostaining for the pronephric 
tubules and duct using a Cy3-conjugated secondary antibody is shown as red fluorescence. The injected side 
is indicated. Pronephric tubules: pt, pronephric duct: d, coiled duct: cd, bar = 300µm. (B). Box-and-whisker 
plots representing pronephric size in injected versus non-injected sides after expression of HNF1β proteins. 
Boxes include 75% of the values, the vertical line represents the group median and whiskers represent the 
outer quartile. The P-values comparing each group to the reference group are shown at the immediate right, 
and the animal number per group is shown in parenthesis. The P-value comparing Myc-HNF1β to GFP-
HNF1β is shown at far right. The reference group was GFP-injected control animals. 
To monitor the morphogenetic potential of the fusion construct, the injected embryos with 
strong GFP fluorescence were raised to free swimming tadpoles (stage 45), and 
immunostained to visualize the pronephros. Monoclonal antibodies for both the pronephric 
tubules and duct were used so that the entire pronephros was stained (Vize et al., 1995). 
Example of dorsal and lateral views of such larvae are shown in Figure 4. The size of the 
pronephros was measured from the lateral view (Figure 5A). The phenotypic effects of 
overexpression were analyzed by comparing the injected to the uninjected sides of the stage 
44-45 embryo (Figure 5B). Pronephric development was analyzed only in otherwise 
phenotypically normal embryos. The expression of HNF1β protein was compared with 
GFP control-injected embryos. The Mann-Whitney test was used to compare the 
measurements obtained from each group of embryos, and differences were considered 
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significant when P < 0.01 (Figure 5B). As has been previously shown for myc-HNF1β 
(Wild et al., 2000; Bohn et al., 2003), the expression of the GFP-HNF1β fusion protein led 
to a significant reduction in the size of the pronephros (Figure 5B). There was no 
significant difference between the effect of GFP-HNF1β compared to myc-HNF1β (P = 
0.217), indicating that GFP does not influence the function of HNF1β in GFP-HNF1β 
fusion protein. Taken together, these data show that the GFP-HNF1β fusion protein is 
functionally equivalent to the myc-HNF1β protein in the cellular as well as whole embryo 
context.  
2. The specificity of HNFβ on pronephric development 
Three human proteins were tested for their functional roles in kidney development in 
Xenopus embryos. One is the protein product of a gene associated with Oral Facial Digital 
Syndrome Type 1 (OFD1). OFD1 syndrome is an X-linked dominant condition which is 
lethal in the male, and is characterized by malformations of the face, oral cavity, and digits 
(Wettke-Schafer and Kantner, 1983; Donnai et al., 1987). The OFD1 gene, located on 
Xp22, has been shown to be mutated in a limited set of OFD1 patients (Feather et al., 
1997). The OFD1 protein is expressed in the metanephric mesenchyme in human embryos, 
and plays a role in the differentiation of metanephric precursor cells (Romio et al., 2003). 
Consistent with this, polycystic kidney disease is commonly associated with OFD1 
(Connacher et al., 1987; Donnai et al., 1987; Scolari et al., 1997). The OFD1312delG 
mutation, a single G deletion at nucleotide 312, was identified in an OFD1 syndrome 
family (Ferrante et al., 2001). The expression of this human mutation in Xenopus embryos 
had no significant effect on pronephric development (Figure 6). Osteopontin (OPN) is a 
multifunctional protein highly expressed in bone, and expressed to a lesser extent in various 
cell types including macrophages, endothelial cells, smooth muscle cells and epithelial cells 
(O'Brien et al., 1994; Malyankar et al., 1997). In rat, OPN is expressed both in the 
developing nephron and ureteric bud, and regulates kidney morphorgenesis in vitro (Rogers 
et al., 1997; Denda et al., 1998). The overexpression of OPN in Xenopus embryos did not 
have an effect on phenotypic size (Figure 6). Neither expression of OPN nor OFD1  
interfered with kidney development in Xenopus embryos. These results indicate that the 
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function of the HNF1β protein is specific in the nephrogenesis and also conserved for all 
vertebrates. 
 
 
Figure 6. Expression of other human proteins known to hinder 
mammalian nephrogenesis in Xenopus does not reduce pronephric 
size. Box-and-whisker plots are shown comparing each group to the 
reference group. Boxes include 75% of the values, the vertical line 
represents the group median and whiskers represent the outer quartile. 
The P-values comparing each group to the reference group are shown at 
the right, and the animal number per group is shown in parenthesis. 
Note that only the XHNF1β-injected group was significantly different 
than the reference group. The reference group was GFP-injected 
control animals. 
The expression of human HNF1β in Xenopus embryos led to agenesis of the pronephros 
(Wild et al., 2000; Bohn et al., 2003). In order to test whether human HNF1β is functionally 
equivalent to Xenopus HNF1β (XHNF1β) in this aspect, mRNA encoding the XHNF1β 
was coinjected with GFP mRNA (Vignali et al., 2000). Overexpression of XHNF1β in 
Xenopus embryos also led to a significant reduction of pronephric size (Figure 6). This 
result supports that the function of HNF1β in nephrogenesis is conserved from Xenopus to 
human. 
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3. Investigation of HNF1β domain functions using HeLa cells and 
Xenopus embryos                                                                                  
3.1 Construction of chimeric proteins for domain function experiments  
It has been previously shown that the HNF1α protein plays no role in nephrogenesis (Wild 
et al., 2000). Based on this fact, I chose to use the HNF1α protein as an inactive backbone 
to construct chimeric proteins containing domains from HNF1β. In order to confirm that 
expression of the truncated HNF1α protein (HNF1aaa) has no effect on kidney 
development, HNF1aaa mRNA was coinjected with GFP mRNA into one blastomere at the 
2-cell stage embryos. Injected embryos were raised to free swimming tadpoles (stage 44-
45) and processed to visualize the pronephros using a mixture of monoclonal antibodies 
against proteins specific for the pronephric tubules and duct. Only embryos that were 
otherwise phenotypically normal were scored for effects on pronephric development. As 
expected, expression of the truncated HNF1α protein had no effect on kidney development 
(Figure 10). These data confirm that the truncated HNF1α protein could not interfere with 
kidney development as has been shown for the full-length HNF1α protein (Wild et al., 
2000). To assure that the injected mRNAs were translated in the embryo, total protein was 
extracted from embryos exhibiting strong GFP fluorescence at the late gastrula stage. A 
western blot using the Myc antibody was performed to visualize the non-embryonic 
proteins. All constructs tested (HNF1aaa, HNF1bbb, HNF1aab and HNF1aabins26) were 
translated into proteins, as they could be detected using the Myc antibody (Figure 7). These 
constructs and their implication on HNF1β function will be discussed more fully below. 
 
 
Figure 7. HNF1 chimeric protein expression in 
Xenopus embryos. Western blot analysis of total 
protein extracts form injected late gastrula stage 
embryos probed with the Myc antibody. The total 
protein from one embryo was separated in each lane. 
The 50 and 75 kDa molecular weight standards are 
indicated. 
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3.2 The conserved 26 aa segment of HNF1β plays a role in gene transactivation. 
A 26 aa segment is present in the HNF1β-A splice variant of HNF1β, but deleted in the 
HNF1β-B splice variant. This segment exists in both the Xenopus and human HNF1β 
proteins, and is 88.5% identical at the protein level (Figure 1). The significance of this 
segment in kidney development was explored next. Two constructs lacking this 26 aa 
region were created (Figure 8A). The HNF1βD construct represents the HNF1β-B splice 
variant, as the 26 aa segment is deleted in the full-length HNF1β protein. The 26 aa 
segment was deleted from a truncated HNF1β protein (HNF1bbb) retaining the 
dimerization domain and the regions involved in DNA binding in the HNF1bbbD construct. 
The truncated protein (HNF1bbb) corresponds to the human Y352insA HNF1β mutation,  
and was shown in previous experiments to be sufficient to induce agenesis of the 
pronephros in Xenopus embryos (Bohn et al., 2003). A truncated HNF1α protein 
(HNF1aaa) lacking the transactivation domain was also generated. Additionally, the 26 aa 
segment was inserted between the POUS and POUH domains of truncated HNF1α 
(HNF1aaains26 construct, Figure 8A). The 26 aa segment is normally not present in the 
HNF1α protein.  
The subcellular localization of these constructs was first assayed in transfected HeLa cells. 
Previous experiments have shown that HNF1α is localized primarily in the nucleus but to a 
lesser extent in the cytoplasm (Thomas et al., 2002). Localization of HNF1β is, however, 
exclusively nuclear (Bohn et al., 2003). To define the subcellular distribution of these 
various proteins, GFP-fusions of these constructs were expressed in HeLa cells. All 
HNF1β-derived constructs (HNF1β, HNF1βD, HNF1bbb and HNF1bbbD) were 
exclusively in the nucleus (Figure 8B). In contrast, the HNF1aaa and HNF1aaains26 
constructs were present in both the nucleus and cytoplasm (Figure 8B). These expression 
patterns correlate well with previous published observations. 
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Figure 8. The 26 aa segment of the HNF1β protein is not responsible for nuclear localization. (A) The 
domains included in these HNF1 constructs are shown diagrammatically. HNF1β is shown in purple and 
HNF1α in blue. The black box indicates the 26 aa segment deleted from the HNF1β splice variant B.(B) 
Subcellular localization of the HNF1 constructs shown in A. Transiently transfected HeLa cells are shown 
under bright field and green fluorescence. bar = 10µm. 
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Figure 9. Transactivation potential of HNF1 constructs with deletion or insertion of the 26 aa segment. 
(A-C) Increasing amounts (5, 10, 30, 50, 150, 300ng) of the GFP-HNF1 expression construct indicated were 
cotransfected into HeLa cells together with an HNF1-dependent luciferase reporter plasmid. The fold-
activation induced by each of the HNF1 expression constructs is shown. Error bars indicate standard deviation 
of the mean of at least six replicates.  
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The transactivation potential of the HNF1 domain function constructs were investigated. 
Expression vectors encoding these proteins were cotransfected into HeLa cells lacking 
endogenous HNF1 proteins together with a luciferase reporter plasmid containing an HNF1 
inducible promoter. Deletion of the 26 aa segment reduced the transactivation potential 
approximately 30% compared to the full-length HNF1β transcription factor (Figure 9A). As 
previously observed (Bohn et al., 2003), the truncated HNF1β protein (HNF1bbb) lacking 
the transactivation domain retained substantial transactivation potential (11-fold, compare 
HNF1bbb with HNF1β in Figure 9B). Typically, HNF1bbb was less active at lower 
concentrations (10-50ng), but was as active as the full-length protein when 3-6 times the 
plasmid amount was transfected. The truncated HNF1β protein lacking the 26 aa segment 
(HNF1bbbD) transactivated the reporter gene to a similar level (12-fold) as the truncated 
HNF1β protein (HNF1bbb, Figure 9C). The truncated HNF1α protein (HNF1aaa) 
transactivated the reporter plasmid at a low level (4.5-fold) when high plasmid 
concentrations were transfected (300ng, Figure 9B). As the known transactivation domain 
is missing from the HNF1α truncated protein, this should be considered as residual activity. 
As expected, the full-length HNF1α protein transactivated the reporter gene at a high level 
(18-fold for 300ng, data not shown). These date are consistent with the initial description of 
the HNF1α transcription factor localizing the activation domain to the C-terminus (Nicosia 
et al., 1990; Sourdive et al., 1993). Insertion of the β-specific 26 aa segment into the 
truncated HNF1α protein abolished residual transactivation (1.7-fold) (Figure 9C). This 
indicates that the 26 aa segment plays distinct roles depending on the context of the rest of 
the protein. 
3.3 The conserved 26 aa segment of HNF1β interferes with pronephric 
development in Xenopus embryos. 
The morphogenetic potential of the various HNF1 constructs were examined in the 
developing Xenopus embryos by injecting mRNA encoding these proteins into one 
blastomere of the two-cell stage embryo. As initial experiments revealed that the GFP-
HNF1β fusion protein fluorescenced too weakly for the identification of the injected side 
(Figure 4), GFP mRNA was coinjected with mRNA for the myc-tagged versions of the 
constructs (Figure 5). Injected embryos were raised to free swimming tadpoles (stage 44-
 
Results   
 
34
45) and processed to visualize the pronephros using a mixture of monoclonal antibodies 
against proteins specific for the pronephric tubules and duct. Only embryos that were 
otherwise phenotypically normal were scored for effects on pronephric development. 
Examples of dorsal views of such larvae are given in Figure 10A. The pronephric size was 
measured in the lateral view of the larvae, and the quantification of these phenotypic 
changes together with the statistical analysis for significance are summarized in Figure 
10B.  
As found previously (Wild et al., 2000; Bohn et al., 2003), expression of full-length 
HNF1β led to a significant reduction of pronephric size (Figure 10), and this effect was 
even more pronounced for the HNF1β truncated protein (HNF1bbb, Figure 10). 
Surprisingly, the full-length HNF1β protein lacking only the 26 aa segment (HNF1βD) had 
no effect on pronephric size (Figure 10). As expected, expression of neither the full-length 
nor the truncated HNF1α protein (HNF1aaa) had any effect on pronephric development 
(Figure 10, (Wild et al., 2000) The insertion of the 26 aa segment into the truncated HNF1α 
protein (HNF1aaains26) led to a reduction of size of the pronephros (Figure 10), implying a 
crucial role for this segment in nephrogenesis. Expression of  the truncated HNF1β-protein 
(HNF1bbbD) lacking this 26 aa segment continued to produce pronephric agenesis (Figure 
10). However, a dramatic gastrulation defect at the injected side was observed when this 
protein was expressed (Figure 11A and B), and more than 90% of the embryos in this group 
died during gastrulation. Even if the amount of HNF1bbbD mRNA injected was halved, 
70% of the embryos died during gastrulation. The majority of the surviving tadpoles were 
distorted compared to control animals (Figure 11D-F, C). Therefore, a relatively small 
number (36) of healthy larvae were available for immunostaining and the examination of 
pronephros-specific effects. Nevertheless, this group size was sufficient for significance 
analysis. This abnormal development was not observed with any of the other constructs.  
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Figure 10. The HNF1β-specific 26 aa segment plays a role in nephrogenesis. (A) Dorsal view of larvae 
(stage 44-45) expressing the HNF1 chimeric proteins shown in Fig. 8. Whole-mount immunostaining for the 
pronephric tubules and duct using a Cy3-conjugated secondary antibody is shown as red fluorescence. The 
injected side is marked by an arrow. bar = 300µm. (B) Box-and-whisker plots representing pronephric size in 
injected versus non-injected sides after expression of HNF1 proteins. Boxes include 75% of the values, the 
vertical line represents the group median and whiskers represent the outer quartile. The P-values comparing 
each group to the reference group are shown at the right, and the animal number per group is shown in 
parenthesis. The reference group was GFP-injected control animals. 
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Figure 11. Xenopus embryos expressing truncated HNF1β lacking the 26 aa segment. Example of 
gastrulation defects observed in 70% of embryos under (A) bright field or (B) green fluorescence. Note cell 
death was only observed in the injected (GFP positive) region. bar = 300µm. (C) Stage 44-45 control embryo 
injected with GFP alone. bar = 1mm. (D-F) Developmental defects observed in tadpoles expressing the 
truncated HNF1β protein lacking the 26 aa segment (HNF1bbbD). Animals shown in panel D and E were not 
scored for pronephric morphology.  
3.4 Function of the dimerization domain of HNF1β 
As expression of the truncated HNF1β protein lacking the 26 aa segment (HNF1bbbD) also 
resulted in a smaller pronephros (Figure 10), protein areas other than the 26 aa segment 
appear to interfere with nephrogenesis. To explore the function of the dimerization domain 
of the HNF1β protein, chimeras of the HNF1α and HNF1β proteins were constructed by 
exchanging the dimerization domains between HNF1α and HNF1β as shown in Figure 
12A. The molecular and cellular properties of these chimeric constructs were assayed in 
transfected cells as well as in developing Xenopus embryos.  
Transfection of the chimeric HNF1 constructs together with an HNF1-dependent luciferase 
reporter plasmid was used to measure transactivation activity in HeLa cells. Only the 
construct encoding the POUS and POUH domains of the HNF1β protein (HNF1abb) 
resulted in transactivation of the reporter gene similar to that mediated by the truncated 
HNF1β protein (HNF1bbb, Figure 12C). The presence of the HNF1β dimerization domain 
in the chimeric protein (HNF1baa) was not sufficient for substantial transactivation of the 
reporter.  
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Figure 12. Cellular properties of the
HNF1β dimerization domain. (A) 
HNF1α/HNF1β chimeric proteins. The
domains included in each chimeric protein 
are shown diagrammatically. HNF1β is 
shown in purple and HNF1α in blue. The
black box indicates the 26 aa segment 
deleted from the HNF1β splice variant B.
Dim: dimerization domain. (B) Subcellular 
localization after expression in HeLa cells. 
Both bright field and green fluorescence is 
shown. bar = 10µm. (C) Transactivation
activity of increasing amounts (5, 10, 30, 
 
 
 
 
 
50, 150, 300ng) of HNF1 chimeric expression constructs that were cotransfected into HeLa cells with an 
HNF1-dependent luciferase reporter plasmid. The fold-activation induced by each of the HNF1 chimeric 
expression constructs is shown. Error bars indicate standard deviation of the mean of at least six replicates.  
The influence of the chimeric HNF1 constructs on kidney development was tested by 
expression experiments in Xenopus embryos. Expression of either the HNF1β dimerization 
domain (HNF1baa) in the truncated HNF1α protein or the HNF1β DNA binding domains 
fused to the HNF1α dimerization domain (HNF1abb) led to a reduction in pronephric size 
(Figure 13). This indicates that the dimerization domain as well as the DNA binding 
domain of HNF1β interfere with pronephric development. However, expression of the 
fusion protein containing the HNF1β dimerization domain was less efficient at reducing 
pronephric size than expression of the protein containing the HNF1β POUS and POUH 
domains (Figure 13), implying that the HNF1β dimerization domain contributes to 
nephrogenesis, but not to the same extent as the DNA binding domains.  
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Figure 13. Functional analysis of the HNF1β dimerization domain in nephrogenesis.  (A) Pronephric 
phenotype in Xenopus larvae expressing HNF1 chimeric proteins. Dorsal view of larvae (stage 44-45) 
expressing the HNF1 chimeric proteins shown in Fig 12. Whole-mount immunostaining for the pronephric 
tubules and duct using a Cy3-conjugated secondary antibody is shown as red fluorescence. The injected side 
is marked by an arrow. bar = 300µm. (B) Box-and-whisker plots representing pronephric size in injected 
versus non-injected sides. Boxes include 75% of the values, the vertical line represents the group median and 
whiskers represent the outer quartile. The P-values comparing each group to the reference group are shown at 
the right, and the animal number per group is shown in parenthesis. The reference group was GFP-injected 
control animals. 
3.5 The homeodomain of HNF1β is essential for nuclear localization and interferes 
with pronephric development.  
To explore the function of the HNF1β homeodomain (POUH) in more detail, chimeric 
constructs were created containing various parts of the HNF1β homeodomain region in a 
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truncated HNF1α protein (HNF1aaa). The chimeric gene constructs generated are shown 
diagrammatically in Figure 14A. The molecular and cellular properties of these chimeric 
constructs were assayed in transfected HeLa cells as well as in developing Xenopus 
embryos.  
  
Figure 14. Cellular properties of  HNF1β POUH domain. (A) The domains included in the HNF1 
chimeric constructs are shown diagrammatically. HNF1β is shown in purple and HNF1α in blue. The black 
box indicates the 26 aa segment deleted from the HNF1β splice variant B. (B) Transactivation activity of 
POUH domain. Increasing amounts (5, 10, 30, 50, 150, 300ng) of these expression constructs were 
cotransfected into HeLa cells together with an HNF1-dependent luciferase reporter gene. The fold-
activation induced by each expression construct is shown. Error bars indicate standard deviation of the 
mean of at least six replicates. (C) Subcellular localization of the chimeric proteins. Bright field and 
fluorescence microscopy of HeLa cells expressing GFP fusion proteins are shown. bar = 10µm  
All chimeric constructs (HNF1aabins26, HNF1abb, HNF1aabH, HNF1aabHS) containing 
the HNF1β homeodomain were found exclusively in the nuclear compartment, implying 
that this domain contributes to the nuclear localization (Figure 14C). The truncated HNF1 
protein (HNF1aaa) was localized both in the cytoplasm and the nucleus (Figure 8B). All 
chimeric constructs containing the HNF1β homeodomain were less active at transactivating 
the HNF1-dependent reporter gene than the truncated HNF1β protein in transfection assays 
 
Results   
 
40
(Figure 14B). The construct containing the HNF1β POUH domain (HNF1aab) was more 
active (5.5-fold) than the truncated HNF1α protein (HNF1aaa). The chimeric construct 
lacking the C-terminal transactivation region (aa 320-351, HNF1aabH) transactivated the 
reporter similar to the truncated HNF1α protein (apprx. 4-fold). The chimeric protein 
containing the β-specific 26 aa segment (HNF1aabins26) transactivated the reporter only 3-
fold (Figure 14B). Crystalographic experiments have shown previously that the DNA 
binding domains of HNF1α lacking the C-terminal 8 aa of the POUH domain could still 
form a complex with the high-affinity promoter DNA (Chi et al., 2002). The deletion of the 
corresponding amino acids in the HNF1β protein (aa 311-319, HNF1aabHS) reduced 
transactivation activity the most (Figure 14B), resulting in only a 2-fold activation. These 
data support a role for both the POUH and POUS domains in transactivation of HNF1β 
target genes. 
To identify whether the homeodomain influences kidney development in Xenopus embryos, 
mRNA for chimeric constructs were injected into one cell at the 2-cell stage, and the 
pronephric size was measured at stage 44-45 (Figure 15). Expression of truncated HNF1α 
proteins containing the entire HNF1β POUH domain (HNF1aab, HNF1aabins26 and 
HNF1aabH) led to a reduction of pronephric size (Figure 15). However, the HNF1β 
homeodomain alone (HNF1βHomeo) had no effect on pronephric size (Figure 15). 
Expression of the HNF1α chimera containing the HNF1β POUH domain lacking the C-
terminal 8 aa (HNF1aabHS) also had no effect on pronephric size. These results indicate 
that the entire HNF1β POUH domain can interfere with kidney development, but only in the 
context of the HNF1 backbone. Expression of two of the truncated HNF1 chimeric 
constructs containing the entire HNF1β POUH domain but lacking the 26 aa segment 
(HNF1aab and HNF1aabH) also resulted in gastrulation defects, as was observed for the 
truncated HNF1β construct lacking the 26 aa segment (HNF1bbbD, Figure 11D-F). In fact, 
approximately 60% of the injected animals (45/113 and 42/104, respectively) showed 
developmental defects not concerning the kidney, allowing only a minority to be analyzed 
at stage 44-45. However, this group was adequate for statistical analysis. Expression of the 
chimeric protein lacking the C-terminal 8 aa of POUH domain (HNF1aabHS) resulted in no 
developmental abnormalities. Taken together, these data indicate that the entire 
homeodomain of HNF1β is required to interfere with renal development.  
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Figure 15. Functional analysis of the HNF1β POUH domain in nephrogenesis. (A) Pronephric phenotype 
in Xenopus. Dorsal view of larvae (stage 44-45) expressing the HNF1 chimeric proteins shown 
diagrammatically in Fig. 14. Whole-mount immunostaining for the pronephric tubules and duct using a Cy3-
conjugated secondary antibody is shown as red fluorescence. The injected side is marked by an arrow. bar = 
300µm. (B) Box-and-whisker plots representing pronephric size in injected versus non-injected sides after 
expression of HNF1 proteins. Boxes include 75% of the values, the vertical line represents the group median 
and whiskers represent the outer quartile. The P-values comparing each group to the reference group are 
shown at the right, and the number of animals per group is shown in parenthesis. The reference group was 
GFP-injected control animals. 
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4. HNF1β partially rescues the Pax8/lim1-mediated nephrogenic 
phenotype.  
It has been reported that overexpression of the transcription factors, Pax8 and lim1, in 
Xenopus embryos led to the development of an abnormally large pronephros as well as the 
formation of ectopic pronephric tubules (Carroll and Vize, 1999). Both of these 
transcription factors are expressed at the neurula stage together with HNF1β in the 
pronephric anlage. Since the overexpression of HNF1β led to agenesis of the pronephros, it 
is possible that a simple antagonistic relationship exists between HNF1β and Pax8/lim1. In 
this case, it would be expected that coexpressing HNF1β would rescue the Pax8/lim1-
induced nephrogenic phenotype. 
Overexpression of Pax8 or lim1 by themselves caused a mild nephrogenic phenotype that 
was difficult to quantify, but synergized to have a pronounced effect. At the 2-cell stage, 
mRNA for Pax8 and lim1 were coinjected into one blastomere together with GFP mRNA. 
Injected embryos were raised to the swimming tadpole stage (stage 44-45), and processed 
to visualize the pronephric tubules and duct. Overexpression of Pax8 together with lim1 led 
to an enlargement of the pronephros as compared to embryos injected with GFP alone 
(Figure 16). This size difference was shown to be significant using the Mann-Whitney test 
(Figure 16G). Ectopic pronephric tubules and cyst-like structures close to the main body of 
the pronephros were also observed in 16% of this group on the injected sides (Figure 16B, 
Table 2). Such structures were never observed in animals only expressing GFP or 
expressing any other HNF1 chimeric protein. Furthermore, the 24% of the larvae 
coexpressing Pax8 and lim1 displayed a thickening of the tubules on the injected side 
(Figure 16A). Such abnormalities were only observed in 4% of the larvae expressing 
truncated HNF1β (HNF1bbb, Table 2). These results are similar to those reported 
previously using a slightly different injection protocol (Carroll and Vize, 1999). The 
pronephri of embryos coexpressing Pax8, lim1 and HNF1β were similar to embryos 
expressing only Pax8 and lim1 (Figure 16C and D). The pronephros appeared smaller in 
some embryos also expressing HNF1β, but the size difference was not significant when 
compared with embryos injected with Pax8 and lim1 alone (Figure 16G). Furthermore, as 
in the group expressing only Pax8 and lim1, 17% of the group also expressing HNF1β were 
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found to have ectopic tubules and 27% exhibited cyst-like structures or thickened tubules 
(Table 2). 
 
Figure 16: Partial rescue of Pax8/lim1-induced kidney malformation by HNF1β. (A-F) Lateral views of 
two representative larvae expressing the proteins listed at the left on one side. Larvae are immunostained to 
visualize the pronephric tubules and duct. (A, B) Enlarged pronephri in Pax8/lim (125 pg mRNA 
each/embryo) coinjected embryos. (C, D) Enlarged pronephri in embryos coinjected with Pax8 (125 pg 
mRNA/embryo), lim1 (125 pg mRNA/embryo), and HNF1β (250 pg mRNA/embryo). (E, F) Reduced 
pronephric size in embryos coinjected with Pax8 (125 pg mRNA/embryo), lim1 (125 pg mRNA/embryo) and 
truncated HNF1β (HNF1bbb, 250 pg mRNA/embryo). Anterior is to the left for the injected sides, to the right 
for the non-injected sides, and dorsal is up. Thickened tubules (T) and cyst-like structures or bubbles (B) are 
indicated by arrows. Ectopic pronephric tubules are indicated by arrow heads. bar = 200µm. (G) Statistical 
analysis of pronephric size in injected versus non-injected sides after expression of the proteins indicated at 
the left. Boxes include 75% of the values, the vertical line represents the group median and whiskers represent 
the outer quartile. The P-value comparing each group to the reference group is shown at the immediate right, 
and the animal number per group is shown in parenthesis. The P-values comparing the Pax8/lim1 expressing 
group to either the group coexpressing full-length or truncated HNF1β are shown at the far right. The 
reference group was GFP-injected control animals. 
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Table 2. Frequency of enlarged or ectopic pronephric tubules in Xenopus embryos 
  
                                                    Pronephric  Tubules   (%)                          Cyst-like structures 
Proteins                                                                                                         or thickened tubules   N 
Expressed                       Enlargeda      Normalb       Smallerc       Ectopic             (%)           
                   
                                             
Pax8 + lim1                           49               34                   1                  16                     24               83 
 
Pax8 + lim1+ HNF1β           40                38                   5                  17                     27               77 
  
Pax8 + lim1 + HNF1bbb      20                38                  42                  0                      28              111 
  
HNF1bbb                              5                  17                  78                  0                       4               226 
 
a relative pronephric size of the injected side/uninjected side > 120% 
b relative pronephric size of the injected side/uninjected side between 80%-120% 
c relative pronephric size of the injected side/uninjected side < 80% 
These data imply that the overexpression of Pax8 and lim1 is dominant to the effect of 
HNF1β. It was not possible to injected higher concentrations of HNF1β mRNA, otherwise 
the RNA injection may produce nonspecific defects in injected Xenopus embryos. Since 
truncated HNF1β (HNF1bbb) was more active in injected embryos for the reduction of the 
pronephric size (Figure 10), this construct was coinjected with Pax8/lim1. These embryos 
had slightly smaller pronephroi in the injected side (Figure 16F), suggesting that expression 
of the truncated HNF1β protein could overcome this effect mediated by Pax8 and lim1. 
More importantly, no larvae had ectopic tubules (Table 2). Surprisingly, 28% of the 
samples exhibited cyst-like structures or thickening of the tubules (Figure 16E and F, Table 
2). These results suggest that HNF1β activity can overcome part of the nephrogenic 
potential of Pax8 and lim1. Most importantly, the data also reveal that Pax8/lim1 and 
HNF1β are not simple antagonists during nephrogenesis, but that Pax8/lim1 also have 
distinct morphogenetic properties.  
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IV. Discussion 
1. Functional properties of the HNF1β domains 
1.1 Homeodomain is responsible for nuclear localization of the HNF1β protein. 
I have shown here that all chimeric proteins containing the HNF1β POU homeodomain 
(POUH) were exclusively localized in the nucleus in transfected HeLa cells. This finding is 
consistent with previous published observations that all mutated forms of the 
HNF1β transcription factor lacking the POUH domain were excluded from the nucleus 
(Bohn et al., 2003). A nuclear localization signal (NLS) is predicted in the N-terminal 
region of the POUH domain of HNF1β (PredictNLS Online 
http://www.cubic.bioc.columbia.edu /predictNLS), but no potential NLS was found in the 
HNF1α protein. The amino acid sequence, KKMRRNR (amino acid 229 to 235, Figure 17), 
is the predicted NLS in the HNF1β protein. The corresponding sequence of the HNF1α 
protein (KKGRRNR) differs by only one amino acid (M to G). This change may hinder 
efficient nuclear translocation of HNF1α in transfected HeLa cells, and probably results in 
nuclear as well as cytoplasmic localization typical for HNF1α in transfected HeLa cells. 
Taken together, the KKMRRNR sequence in the homeodomain is most likely the NLS of 
the HNF1β protein. 
1.2 The POUS and POUH domains are responsible for most of the transactivation 
activity of the HNF1β protein.  
Deletion of the area of the HNF1β protein corresponding to the transactivation domain of 
the HNF1α protein did not abolish transactivition activity. Although the truncated HNF1β 
protein was slightly less effective at transactivating the reporter gene at low plasmid 
concentrations, the same maximal level of transactivation was reached at saturating plasmid 
concentrations. The N-terminal region includes the dimerization domain and two DNA 
binding domains, known as the POUS and POUH domains. I have shown here that the 
dimerization domain of the HNF1β protein has no transactivation activity. Replacement of 
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either the POUS and POUH domains or the POUH domain alone in the HNF1α protein 
lacking the transactivation domain partially restored the transactivation potential. Even 
though the POUS and POUH domains are highly conserved between the HNF1α and HNF1β 
proteins, there appears to be functional differences. As a progressive increase was observed 
in the transactivation potential with the length of the β-protein derived segment, several 
features probably contribute to the transactivation potential of the POUS and POUH 
domains of HNF1β. The 26 aa segment located between the POUS and POUH domains of  
the HNF1β is evolutionarily highly conserved from Xenopus to human. This segment, 
deleted in splice variant HNF1β-B, is the most striking difference between the HNF1α and 
HNF1β proteins (Cereghini et al., 1992). I have shown here that the 26 aa segment 
contributes differently to transactivation potential based on the context of the rest of the 
protein. In the full-length HNF1β protein, it accentuated transactivation activity. This is 
consistent with previous results showing that the HNF1β splice variant B lacking this 26 aa 
segment was less effective at transactivating the reporter gene (Ringeisen et al., 1993; 
Haumaitre et al., 2003). Deletion of this segment from the truncated HNF1β protein made 
no difference on its transactivation potential. Finally, the insertion of this segment into the 
HNF1α protein lacking the transactivation domain abolished residual transactivation 
activity. The 26 aa segment may interact in a context-dependent manner with other 
transcription factors or components of the basal transcriptional machinery to cause these 
differences. Although the C-terminal region of the HNF1β protein is often referred to in the 
literature as the transactivation domain, I have shown here that primarily the POUS and 
POUH domains of the HNF1β protein carry out this function. 
1.3 Domains of HNF1β involved in nephrogenesis 
1.3.1 The effect of HNF1β on pronephros formation is conserved.  
Although the analysis in this study was concentrated on HNF1 proteins of human origin, it 
is unlikely that protein functions are species specific. Both Xenopus and humans have 
homologs of the HNF1α and HNF1β proteins (Bartkowski et al., 1993; Demartis et al., 
1994). As I have shown here, overexpression of either XHNF1β or hHNF1β in Xenopus 
embryos inhibited pronephric development, supporting the conserved function of HNF1β 
from Xenopus to humans. Only overexpression of HNF1β causes agenesis of the 
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pronephros in the Xenopus model system. Overexpression of HNF1α has no effect on 
development, even though they are closely related transcription factors (Wild et al., 2000). 
Expression of two other human proteins known to be involved in mammalian kidney 
development had no effect on pronephric development in Xenopus. OFD1 is the gene 
responsible for OFD1 syndrome, and is commonly associated with polycystic kidney 
disease in humans (Connacher et al., 1987; Donnai et al., 1987; Scolari et al., 1997). The 
function of this protein remains unclear. In work shown here, expression of the 
OFD1312delG mutant in Xenopus had no significant effect on pronephric development. 
This mutant is a truncated protein only containing the predicted N-terminal lish motif (aa 
68-101), but lacking the predicted coiled-coil domains and hepta repeats of this protein. 
(Emes and Ponting, 2001). Coiled-coil domains are involved in protein-protein interactions. 
The absence of critical functional areas of the protein that could be interacting with other 
transcription factors or proteins in transcriptional activating or repressing complexes  may 
be the reason why this mutant did not interfere with pronephric development in Xenopus. 
Further experiments will be necessary to completely elucidate the function of OFD1 in 
nephrogenesis using full-length OFD1 protein and/or other mutants. Osteopontin (OPN), a 
multifunctional protein, is a prominent matricellular component of mineralized tissues of 
bones and teeth (O'Brien et al., 1994; Malyankar et al., 1997). In the rat, OPN is expressed 
both in the developing nephron and in the ureteric bud, and addition of neutralizing 
antibodies to metanephric organ cultures blocked normal metanephric tubulogenesis 
(Rogers et al., 1997). Importantly, OPN was induced by HNF1β in cell cultures, indicating 
it is a potential target gene for HNF1β (unpublished data). However, experiments presented 
in this thesis showed that overexpression of OPN in Xenopus had no effect on pronephric 
development. This implies that OPN may be not responsible for the effect of HNF1β on 
nephrogenesis in Xenopus. It is possible that OPN function in nephrogenesis is not 
conserved between mammalian and non-mammalian vertebrates. Alternatively, since this is 
a secreted protein, it is possible that secretion of the protein and its integration into the 
extracellular matrix was not efficiently carried out by the cells of the Xenopus embryo. 
Taken together, the Xenopus pronephros is good model for examining the nephrogenic 
function of human HNF1β, but not all proteins known to be involved in mammalian kidney 
development. 
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1.3.2 GFP-HNF1β fusion protein is inadequate for examining protein expression at 
later developmental stages. 
Experiments presented here show that the GFP-HNF1β fusion protein is functionally 
equivalent to the myc-HNF1β fusion protein, and therefore the endogenous HNF1β protein, 
in a cellular as well as a whole embryo context. However, the fluorescence of the GFP-
HNF1β fusion protein was inadequate for examining expression at later developmental 
stages in Xenopus embryos. Consequently, four- to five-fold more embryos had to be 
injected to analyze the pronephric phenotype as compared to embryos coinjected with 
mRNA for myc- HNF1β and GFP. The lower GFP fluorescence might be due to an altered 
GFP conformation caused by either the attached linker and HNF1β protein or by cofactors 
binding to HNF1β in vivo. It is reported that the number of linker amino acids is critical for 
the correct expression and/or fluorescence of the GFP (Tavoularis et al., 2001). In Xenopus 
embryos, the DCoH  cofactor binds to HNF1β for proper in vivo function (Pogge 
v.Strandmann et al., 1997). The fluorescence of the GFP-HNF1β fusion protein was strong 
in transfected HeLa cells, which do not express DCoH. Alternatively, since mRNA is 
injected into the Xenopus embryo at the 2-cell stage, some of the mRNA will be degraded 
as development proceeds resulting in lower protein levels. Additionally, the mRNA is split 
up among the cells of the embryo during mitosis, also resulting in a lower concentration of 
mRNA per blasomere. It is likely that a combination of all of these possible explanations 
contribute to the low fluorescence of the GPF-HNF1β fusion protein in Xenopus larvae 
making it unsuitable for pronephric phenotype analysis. 
1.3.3 Three domains in HNF1β are involved in nephrogenesis.  
The Xenopus pronephros is a good system to define the function of proteins involved in 
vertebrate nephrogenesis. Overexpression of HNF1β, but not HNF1α, interfered with 
pronephros formation in Xenopus embryos. Using expression of HNF1α/HNF1β chimeric 
proteins, I have identified three domains of the HNF1β protein that contribute to this effect, 
including the dimerization domain, the 26 aa segment and the homeodomain. It is 
noteworthy repeat that the HNF1β dimerization domain had no transactivation activity in 
HeLa cells. This indicates that the function of HNF1β during nephrogenesis is more 
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complicated than the ability to transactivate a target gene. These results reinforce that 
analysis of protein function using only cell cultures is too simplistic to evaluate protein 
function in a developing organism. The analysis of the morphogenetic potential of chimeric 
HNF1 proteins during kidney development in Xenopus is more meaningful to this end.  
The HNF1β dimerization region used in the experiments presented here includes the 
dimerization domain and part of the linker between the dimerization and POUS domains. 
They may both contribute to reducing pronephric size. For the dimerization domain, nine of 
32 residues differ between the HNF1α and HNF1β dimerization domains. One conservative 
substitution of Val21 in HNF1β for Leu21 in HNF1α is located in a buried position in the 
loop. The other eight residues occupy solvent exposed positions in the HNF1 structure 
(Rose et al., 2000). These surfaces may interact with another segment of HNF1 or with 
other proteins to create the functional differences of HNF1α and HNF1β during pronephric 
development.  
The 26 aa segment located between the POUS and POUH domains of HNF1β plays an 
important role in nephrogenesis. This is most interesting, as this segment is the 
characteristic feature of the splice variant A. Whereas, the full-length splice variant A of 
HNF1β led to agenesis of the pronephros in Xenopus embryos, the splice variant B, lacking 
only the 26 aa segment, did not interfere with pronephric development (Figure 10). The 
ratio of splice variant A to B expression varies during the time of kidney development in 
the mouse (Cereghini et al., 1992). In this light, these results spawn the intriguing 
suggestion that expression changes of differentially spliced HNF1β proteins is an important 
level of control during vertebrate kidney development. The functional difference between 
the A and B splice variants in nephrogenesis contrasts to their role during early murine 
embryogenesis, where either variant can compensate for the loss of the endogenous HNF1β 
gene during the differentiation of visceral endoderm from embryonic stem cells (Haumaitre 
et al., 2003). Consistant with these results, the insertion of 26 aa segment into the 
nephrogenically inactive truncated HNF1α protein led to agenesis of the pronephros. The 
results presented in this thesis strongly support a role for the 26 aa segment of HNF1β in 
vertebrate nephrogenesis. 
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Although deletion of the 26 aa segment from the full-length HNF1β protein (splice variant 
B) blocked the effect on nephrogenesis, deletion of this segment from the truncated HNF1β 
protein did not affect its ability to interfere with pronephric formation. This indicates that 
complex interactions between different domains of the HNF1β protein itself or interactions 
with other proteins may be very important for the proper function of HNF1β in kidney 
development. In fact, chimeric proteins containing the HNF1β homeodomain, but lacking 
the 26 aa segment, also led to agenesis of the pronephros. These results demonstrate the 
importance of the HNF1β homeodomain in kidney development. The region of the 
homeodomain responsible for this effect was restricted to the POUH domain between 229 
and 319 aa. The homeodomain alone was unable to reduce pronephric size, emphasizing 
once again the importance of the remaining protein context for proper function. Deletion of 
the C-terminal 8 aa of homeodomain of the β protein (311-319 aa) abolished its potential to 
interfere with pronephric formation. Although the POUH domain of HNF1α lacking the 
corresponding 8 aa still formed a complex with the high-affinity promoter as shown by X-
ray crystalography (Chi et al., 2002). Since, two amino acids within this 8 aa region (Q311 
and A317) are different in the HNF1α and HNF1β proteins, it is possible that one or both of 
these two amino acids play a functional role of the HNF1β POUH domain during 
nephrogenesis. Alternatively, the entire POUH domain may be necessary for  proper 
function. Nine amino acids differ within the POUH domain when the HNF1α and HNF1β 
proteins are compared (position α versus β:  G199M, F215Y, E119D, T231A, I242L, 
Q250K, Q252H, H279Q, T285A). Three of these have chemically different side groups 
chains (F215Y: from nonpolar to uncharged polar, Q250K: from uncharged polar to basic, 
H279Q: from basic to uncharged polar), and these differences are strictly conserved in all 
vertebrate HNF1α and HNF1β proteins examined to date. These three amino acids in the 
POUH domain may provide the functionality of the HNF1β protein in nephrogenesis. It is 
known that Q250 is involved in the interface between the POUS and POUH domains in the 
HNF1α protein, and this change to lysine (Q to K) in the HNF1β protein most probably 
influences the conformation and flexibility of the DNA binding domain. The substitution of 
methionine for glycine (G199M) may also be important for the conformation and function 
of the HNF1β protein, although this is a conservative change (remains nonpolar).  This 
amino acid is located in the NLS, and could be at least partially responsible for the hindered 
nuclear transport of HNF1α protein in HeLa cells. Additionally, because methionine has a 
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more bulky side chain and is capable of disulfide bonding, other protein interactions may 
be possible. Further experiments will be necessary to determine the significance of these 
amino acids for HNF1β protein function.  
In a recent report, the expression of human HNF1β mutants into Xenopus embryos was 
reported to lead to either a reduction or an enlargement of the pronephros (Bohn et al., 
2003). These observed phenotypes could not be correlated directly to the structure of the 
mutated HNF1β protein (summarized in Figure 17). All truncated HNF1β proteins retaining 
the DNA binding domain (e.g. Y352insA) as well as an HNF1β mutant with an in-frame 
internal deletion in the POUS domain (R137-K161) that destroys DNA binding resulted in a 
reduction in pronephric size. In contrast, all truncated HNF1β proteins with impaired DNA 
binding (e.g. A263insGG and E101X) resulted in an enlargement of the pronephros. In the 
present studies, three regions were identified with nephrogenic potential. It is plausible that 
all three regions must be present in an HNF1β mutant for it to cause a reduction in 
pronephric size, otherwise an enlargement occurs.  
 
Figure 17. The nephrogenic effects of domains in the human HNF1β transcription factor and its 
mutants. Functional domains are indicated above the schematic representation of HNF1β, and numbers refer 
to the amino acid positions. The black box indicates the 26 aa segment deleted in the HNF1β splice variant B. 
The three regions involved in nephrogenesis are marked by black lines beneath the HNF1β diagram. The NLS 
is marked by a red line above the HNF1β diagram. Naturally occurring HNF1β mutations are shown below as 
line diagrams to indicate what regions of the protein are missing. Whether these HNF1β mutants cause an 
enlargement or a reduction of pronephric size  is indicated at the far right (Bohn et al., 2003) 
Expression of truncated HNF1 proteins lacking the 26 aa segment but containing the 
HNF1β homeodomain resulted in 70-80% of the embryos dying during gastrulation and 15-
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20% embryos having general developmental malformations not related to nephrogenesis. It 
is not clear why the expression of these HNF1 proteins caused these early developmental 
problems. One explanation is, that HNF1β has several functions distinct from 
nephrogenesis in early embryogenesis. Knock-out experiments in the mouse established 
that HNF1β is required for yolk sac differentiation (Coffinier et al., 1999b; Barbacci et al., 
1999), and overexpression in Xenopus of a dominant negative form of HNF1β interferes 
with mesoderm induction (Vignali et al., 2000). Furthermore, HNF1β mRNA injection into 
zebra fish showed it to be involved in the specification of the rhombomeres identity in the 
hindbrain (Wiellette and Sive, 2003). It is possible that some of our constructs may have 
disturbed similar early developmental processes outside of the pronephric anlage in the 
frog. Alternatively, these results may be explained by nonspecific gene regulation by these 
proteins. The deletion of the 26 aa segment and/or absence of C-terminal areas of the 
protein may result in a more open 3-dimensional protein conformation which allows 
regulatory proteins increased access to the homeodomain. Expression of these constructs 
may activate a maternal apoptotic program as a “fail-safe” mechanism of early 
embryogenesis (Kai et al., 2003). Hensey and Gautier have proposed that Xenopus 
embryonic cells perform a check shortly after MBT to see if they are physiologically fit 
(Hensey and Gautier, 1997). If a cell is physiologically aberrant at the G1 phase, it executes 
an apoptotic program and dies so that the embryo as a whole can continue normal 
development. The checkpoints may be normal RNA transcription and protein translation. 
However, if a large number of cells are abnormal, movements during gastrulation may be 
disturbed resulting in a surviving embryo with non-lethal malformations. If a critical 
number of abnormal cells is reached, development of the embryo is not able to continue, 
and it dies during gastrulation. It is most likely that the embryo death at gastrulation and 
general malformations observed after expression of these constructs was a result of 
nonspecific gene regulation as a result of binding of many other regulatory proteins to the 
homeodomain.  
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2. HNF1β partially antagonizes the Pax8/lim1-induced nephrogenic 
phenotype 
There are at least two other transcription factors involved in early kidney development in 
vertebrates. In the Xenopus embryo, both Pax8 and lim1 are initially expressed in the 
pronephric anlage at the time when HNF1β is expressed (Ryffel, 2003). Both these 
transcription factors are functionally important, since overexpression of either protein led to 
an enlarged pronephros with ectopic pronephric tubules (Carroll and Vize, 1999). This 
effect was additive when both transcription factors were coexpressed, and the effect of 
Pax8 could be mimicked by Pax2 (Carroll and Vize, 1999), whose expression starts shortly 
after Pax8 in the pronephric anlage (Heller and Brändli, 1999). The importance of lim1 
(Shawlot and Behringer, 1995) and Pax2 (Torres et al., 1995) in mammalian development 
was shown in knockout mice that had severe defects in organogenesis including agenesis of 
the kidney. The nephrogenic role of Pax8 has only been identified in a Pax2-deficient 
background. Mice lacking Pax8 and Pax2 are unable to form any nephric structure due to a 
block in the mesenchymal-epithelial transition (Bouchard et al., 2002).  
I have shown here that overexpression of Pax8 and lim1 resulted in an enlargement of the 
pronephros and the development of ectopic pronephric tubules. This is consistent with 
previous studies using the different injection protocol (Carroll and Vize, 1999). In this 
paper, Pax8 was injected together with lim1 into different regions of the marginal zone of 
16- to 32-cell stage Xenopus embryos in order to restrict expression only to certain areas of 
organ development (Carroll and Vize, 1999). Cells injected included the C-2, C-3, and C-4 
blastomeres of 32-cell-stage embryos (nomenclature of (Dale and Slack, 1987). The C-2 
cells will form the anterior somites and heart, whereas the C-3 cells form more posterior 
somites, pronephroi and part of the lateral plate mesoderm. The C-4 cells form lateral plate 
and ventral mesoderm as well as the posterior somites. Since HNF1β overexpression 
inhibits kidney formation and Pax8/lim1 overexpression is nephrogenic, it is possible that a 
simple antagonism exists between these factors during kidney development. 
Overexpression of the full-length HNF1β protein did not rescue the Pax8/lim1-induced 
nephrogenic phenotype. However, overexpression of the truncated HNF1β protein rescued 
lim1/Pax8-induced enlargement and ectopic tubule formation (Figure 16G). Pax8/lim1-
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induced thickening of tubules and cyst-like structure formation, however, remained 
essentially unchanged (Figure 16E and F). The truncated HNF1β protein was a more potent 
inhibitor of nephrogenesis in the expression experiments presented here. It is likely that the 
ability of the truncated protein, but not the full-length HNF1β protein, to rescue the 
Pax8/lim1 nephrogenic phenotype is a function of the increased activity of the truncated 
protein. These results suggest that Pax8/lim1 and HNF1β are not simple antagonists during 
nephrogenesis, but that Pax8/lim1 also have distinct morphogenetic properties.  
3. HNF1α and HNF1β have acquired different functions during 
evolution 
The tissue-specific transcription factors, HNF1α and HNF1β, are two closely related 
homeodomain factors, and both are expressed in defined embryonic regions including the 
developing kidney during vertebrate development (Mendel et al., 1991; Tronche and Yaniv, 
1992; Pogge v.Strandmann et al., 1997). They display extensive structural similarities with 
indistinguishable DNA sequence binding specificity (Cereghini, 1996). However, they also 
display distinct properties with different expression patterns and distinct phenotypes in 
knock-out mice (Cereghini et al., 1992; Ott et al., 1991; Lazzaro et al., 1992; Barbacci et 
al., 1999; Coffinier et al., 1999a; Reber and Cereghini, 2001; Barbacci et al., 1999; 
Coffinier et al., 1999b; Pontoglio et al., 1996; Pontoglio et al., 1998). Different human 
disease states have been linked to heterzygous mutations of the HNF1α and HNF1β genes 
(see review, (Ryffel, 2001). It has been reported previously that the different expression 
patterns are responsible for the different functions (Haumaitre et al., 2003). However, I 
have shown here that the homologous protein domains have also acquired distinct 
functional properties. The C-terminal transactivation domain is the most divergent region 
between the HNF1 proteins. In most transactivation assays HNF1α is approximately two-
fold more potent than HNF1β (Cereghini, 1996; Wild et al., 2000). The C-terminal 
transactivation domain in HNF1α is responsible for this high transactivation activity. In 
contrast, the POUS and POUH DNA binding domains in HNF1β are required for the 
transactivation activity of HNF1β. The N-terminal three domains are highly conserved 
between the HNF1β and HNF1α proteins. The HNF1β dimerization domain, the 26 aa 
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segment only present in the splice variant HNF1β-A, and the POUH domain contribute to 
nephrogenensis. However, the  HNF1α protein  has no function in nephrogenesis.   
Divergence of protein function across evolution also occurs in other protein families. The 
transcription factors, Pax2 and Pax8, are structurally closely related proteins, but have 
acquired distinct functions during the evolution. Pax proteins are defined by the presence of 
a DNA-binding domain called the paired domain (PD), which makes sequence-specific 
contacts with DNA. In mammals, nine Pax genes have been identified to date. Homologs 
exist in worms, flies, fish, frogs and birds. Pax genes have been divided into four subgroups 
based on genomic structure, sequence similarity and conserved function. Pax2 and Pax8 
belong to the same subgroup containing a PD domain, an octapeptide motif, the first helix 
of the homeodomain, and a carboxy-terminal transactivation domain. Both Pax2 and Pax8 
are expressed in the central nervous system and kidney, but Pax8 is also expressed in the 
thyroid. Some functions of Pax2 and Pax8 appear to be similar in kidney development. 
Whereas mice deficient in Pax2 show defective kidney development, mice lacking Pax8 in 
a Pax2 deficient background are unable to form any nephric structure (Bouchard et al., 
2002). Additionally, Pax8-deficient mice had normal kidneys, but lacked the thyroid gland 
(Mansouri et al., 1998). In humans, haploinsufficiency of Pax2 has been linked to the renal 
coloboma syndrome, an autosomal dominant human disease characterized by renal and 
ocular defects (Eccles, 1998). Conversely, Pax2 overexpression has been associated with 
fetal and infantile multicystic kidneys, autosomal dominant polycystic kidney disease, renal 
cell carcinoma and Wilm’s tumor (Winyard et al., 1996). Humans heterozygous for Pax8 
mutations exhibit hypothyroidism, but no kidney defects (Macchia et al., 1998). Although 
Pax2 and Pax8 are structurally very similar proteins, they have different functions during 
development.  
4. Complex transcriptional regulation in nephrogenesis 
Evidence is accumulating that specific gene transcription is regulated by large complexes of 
proteins including transcriptional activators, repressors, coactivators and corepressors that 
interact with sequence-specific regulatory elements on the DNA and/or various components 
of the general/basal transcription machinery as well as proteins that have a recruiting 
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function for other regulatory proteins and proteins that function as scaffolding elements for 
the binding of many proteins in the active or inactive complex (Bernstein et al., 2000; 
Knoepfler and Kamps, 1995; Wheeler et al., 2000). In light of experiments showing that  
 
 
Figure 18. Model for the inhibition of nephrogenesis by HNF1β 
A cartoon of the functional domains of HNF1β is shown. Unknown 
proteins, X and Y, are coregulators of gene transcription during 
nephrogenesis. red: dimerization domain, blue: POUS domain, green: POUH 
domain, yellow: C-terminal region, red line: 26 aa segment. 
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those transcription regulatory complexes examined contain hundreds of proteins (Holmes 
and Tjian, 2000; Hassel et al., 2004), it is necessary to examine functional domains of 
proteins involved in transcriptional regulation in the context of other possible necessary 
binding proteins. 
I have shown that three domains of the HNF1β protein are involved in nephrogenesis: the 
dimerization domain, the 26 aa segment, and the POUH domain. Using the expression of 
chimeric HNF1α/HNF1β proteins in Xenopus, several functional aspects of the 26 aa 
segment and the POUH domain have come to light. The deletion of the 26 aa segment in 
full-length HNF1β abolished its inhibition of nephrogenesis. However, the chimeric protein 
containing the POUH domain in the context of the truncated HNF1α protein which does not 
have the 26aa segment inhibited nephrogenesis, as does the full-length or truncated HNF1β 
protein. By insertion of the 26 aa segment into the truncated HNF1α protein, a partial gain 
of nephrogenic inhibition could be accomplished. A possible model for how the 
nephrogenic function of HNF1β can be achieved in presented in Figure 18. In light of the 
effects of these proteins during the expression experiments, at least two other proteins must 
be involved to achieve this functionality. These proteins are referred to as protein X and 
protein Y in the figure. I propose that protein Y binds to the 26 aa segment, and helps to 
recruit protein X to bind the POUH domain (Figure 18A). If the 26 aa segment is absent, Y 
cannot bind and protein X cannot be recruited to the full-length protein (Figure 18B). It can 
be imagined that without the 26 aa segment, the 3-dimensional conformation of the HNF1β 
protein assumes a more closed structure, masking the binding site of protein X in the POUH 
domain. If the C-terminal domain is removed, the binding site of the protein X is no longer 
masked due to a more open 3-dimensional conformation of the protein (Figure 18C). In this 
more open conformation, the 26 aa segment and the recruiting function of protein Y are no 
longer necessary for the binding of protein X (Figure 18D). The binding site for protein X 
is likely to be located in the C-terminal 8 aa of the POUH domain, as deletion of these 8 aa 
from the truncated protein abolished the nephrogenic effect (Figure 18E). The large 
proportion of embryos dying after the expression of the truncated protein also lacking the 
26 aa segment can also be explained by this model. Since a more open 3-dimensional 
conformation could also facilitate the binding of many other nonspecific regulatory 
proteins. This could result in several genes being improperly regulated and initiate the cell 
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death program. It is interesting to note that the presence of the 26 aa segment in such a 
truncated protein eliminated the lethal effects of protein expression. This segment may have 
restored more specific binding to the POUH domain in this construct. It will be necessary to 
examine proteins interacting with the different domains of the HNF1β protein to understand 
the molecular function of HNF1β in nephrogenesis.  
In this thesis, three domains of HNF1β were identified to be involved in nephrogenesis. 
These functionally unique features of HNF1β are not only important for understanding the 
distinct roles of HNF1α and HNF1β during development, but may also assist in the 
interpretation of data from human patients with heterozygous mutations in HNF1β, leading 
to a better understanding of the mechanisms of kidney disease. 
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